Name of Cell
|
Registry No.
|
Animal
|
Tissue
|
Description
|
0-9
|
Page Top
|
|
|
|
104C1
|
JCRB9036
|
guinea pig
|
fetal body
|
fetal carcass, benzo(a)pyrene transformed, diploid
|
16-8
|
JCRB0013
|
mouse
|
antibody-producing hybridoma
|
anti-human erythrocyte, IgM
|
19-7
|
JCRB0014
|
mouse
|
antibody-producing hybridoma
|
anti-human erythrocyte, IgM
|
293
|
JCRB9068
|
human
|
kidney
|
transformed embryonal kidney by adenovirus (type5)
|
3LL
|
JCRB1348
|
mouse
|
lung
|
Lewis lung cancer-derived cell line, (C57BL mouse)
|
3'-mRLh-2
|
JCRB0431
|
rat
|
liver
|
hepatoma, (Donryu rat)
|
3'-mRLN-30
|
JCRB0421
|
rat
|
liver
|
liver cell line, 3'-methyl-4-dimethylaminoazobenzene induced, (Donryu rat)
|
3'-mRLN-31
|
JCRB0422
|
rat
|
liver
|
liver cell line, 3'-methyl-4-dimethylaminoazobenzene induced, (Donryu rat)
|
3T3 L1
|
JCRB9014
|
mouse
|
embryo
|
fibroblast, 3T3-Swiss derivative, adipocyte differentiation, (Swiss albino mouse)
|
3T3-L1
|
IFO50416
|
mouse
|
embryo
|
fibroblast, 3T3-Swiss derivative, adipocyte differentiation, (Swiss albino mouse)
|
3T3-Swiss albino
|
IFO50417
|
mouse
|
embryo
|
fibroblast, contact inhibited, (Swiss albino mouse)
|
3T3-Swiss albino
|
JCRB9019
|
mouse
|
embryo
|
fibroblast, contact inhibited, (Swiss albino mouse)
|
3T6-Swiss albino
|
JCRB9059
|
mouse
|
embryo
|
fibroblast, collagen-secreting, (Swiss albino mouse)
|
3Y1-B Clone 1-6
|
JCRB0734
|
rat
|
embryo
|
fibroblast, whole embryo, (Fischer 344 rat)
|
4-2D
|
JCRB0084
|
mouse
|
antibody-producing hybridoma
|
anti-primase complexed with DNA polymerase alpha
|
4-8H
|
JCRB0083
|
mouse
|
antibody-producing hybridoma
|
anti-DNA polymerase alpha, IgG1
|
4G12 hybridoma
|
IFO50090
|
mouse x human
|
antibody-producing hybridoma
|
4G12 antibody, preferentially reacting with lung carcinoma-associated antigen
|
5RP7
|
IFO50277
|
rat
|
embryo
|
fibroblast transformed by c-Ha-ras oncogene
|
6-23 clone 6
|
IFO50270
|
rat
|
thyroid
|
medullary thyroid carcinoma, neurotensin and calcitonin-producing, (WAG/RIJ rat)
|
77N1
|
IFO50280
|
rat
|
kidney
|
transformant of NRK cells by avian sarcoma virus B77, (Osbone-Mendel rat)
|
7D4
|
JCRB9092
|
mouse x rat
|
antibody-producing hybridoma
|
anti-murine IL-2 receptors (rat antibody)
|
8305C
|
JCRB0824
|
human
|
thyroid
|
thyroid anaplastic carcinoma, undifferentiated
|
8505C
|
JCRB0826
|
human
|
thyroid
|
thyroid carcinoma, undifferentiated
|
9-15c
|
JCRB1181
|
mouse
|
bone marrow
|
mesenchymal cell line
|
A
|
Page Top
|
|
|
|
A1
|
IFO50519
|
mouse
|
neural
|
derives from p53-deficient mouse brain, used for preparation of conditioned medium for MG5 cells
|
A-172
|
JCRB0228
|
human
|
neural
|
glioblastoma
|
A2058
|
IFO50276
|
human
|
melanoma
|
malignant melanoma, metastasis to lymph node
|
A2B5 clone 105
|
IFO50284
|
mouse
|
antibody-producing hybridoma
|
A2B5 antibody, recognizing a glycolipid expressed in neural tissue
|
A3/KAW
|
JCRB0101
|
human
|
hemo-lymphocytic
|
lymphoma, malignant
|
A31-1-1
|
JCRB1356
|
mouse
|
embryo
|
fibroblast, subclone of Balb/3T3-A31, (BALB/c mouse)
|
A31-714 C4
|
IFO50021
|
mouse
|
embryo
|
fibroblast, subclone of Balb/3T3 A31, (BALB/c mouse)
|
A4/Fuk
|
JCRB0097
|
human
|
hemo-lymphocytic
|
lymphoma, malignant, B-cell, non-Hodgkin's, IgM kappa-producing
|
A-431
|
IFO50411
|
human
|
epidermoid carcinoma
|
epidermoid carcinoma, high expression of EGF receptor
|
A-431
|
JCRB0004
|
human
|
epidermoid carcinoma
|
epidermoid carcinoma, high expression of EGF-receptor
|
A-431
|
JCRB9009
|
human
|
epidermoid carcinoma
|
epidermoid carcinoma, high expression of EGF-receptor
|
A549
|
IFO50153
|
human
|
lung (cancer)
|
adenocarcinoma
|
A549
|
JCRB0076
|
human
|
lung (cancer)
|
adenocarcinoma
|
A9
|
JCRB0211
|
mouse
|
skin
|
skin fibroblast, 8-azaguanine-resistant, (C3H mouse)
|
A9(0439)-1
|
JCRB0732
|
human chromosome-introduced
|
human chromosomal hybrid
|
contains human chromosome Xpter>Xq26::3p12>3pter
|
A9(2621)-4
|
JCRB0730
|
human chromosome-introduced
|
human chromosomal hybrid
|
contains human chromosome 12pter>12q24::Xq22>Xqter
|
A9(3552)-2
|
JCRB0731
|
human chromosome-introduced
|
human chromosomal hybrid
|
contains human chromosome 11pter>11q23::Xq26>Xqter
|
A9(3884)-1
|
JCRB0729
|
human chromosome-introduced
|
human chromosomal hybrid
|
contains human chromosome 16pter>16q24::Xq26>Xqter
|
A9(7151)-3
|
JCRB0728
|
human chromosome-introduced
|
human chromosomal hybrid
|
contains human chromosome 17pter>17q11::Xq11>Xqter
|
A9(An4)-2
|
JCRB0727
|
human chromosome-introduced
|
human chromosomal hybrid
|
contains human chromosome # 1
|
A9(Bsr10)
|
JCRB2210
|
human chromosome-introduced
|
human monochromosomal hybrid panel
|
contains human chromosome #10
|
A9(BsrX)
|
JCRB2223
|
human chromosome-introduced
|
human monochromosomal hybrid panel
|
contains human chromosome X
|
A9(Hygro13)
|
JCRB2213
|
human chromosome-introduced
|
human monochromosomal hybrid panel
|
contains human chromosome #13
|
A9(Hygro14)
|
JCRB2214
|
human chromosome-introduced
|
human monochromosomal hybrid panel
|
contains human chromosome #14
|
A9(Hygro21)
|
JCRB2221
|
human chromosome-introduced
|
human monochromosomal hybrid panel
|
contains human chromosome #21
|
A9(Hygro22)
|
JCRB2222
|
human chromosome-introduced
|
human monochromosomal hybrid panel
|
contains human chromosome #22
|
A9(Neo1)
|
JCRB2201
|
human chromosome-introduced
|
human monochromosomal hybrid panel
|
contains human chromosome # 1
|
A9(neo11)
|
JCRB2211
|
human chromosome-introduced
|
human monochromosomal hybrid panel
|
contains human chromosome #11
|
A9(Neo12)
|
JCRB2212
|
human chromosome-introduced
|
human monochromosomal hybrid panel
|
contains human chromosome #12
|
A9(Neo15)
|
JCRB2215
|
human chromosome-introduced
|
human monochromosomal hybrid panel
|
contains human chromosome #15
|
A9(Neo16)
|
JCRB2216
|
human chromosome-introduced
|
human monochromosomal hybrid panel
|
contains human chromosome #16
|
A9(Neo17)
|
JCRB2217
|
human chromosome-introduced
|
human monochromosomal hybrid panel
|
contains human chromosome #17
|
A9(Neo18)
|
JCRB2218
|
human chromosome-introduced
|
human monochromosomal hybrid panel
|
contains human chromosome #18
|
A9(Neo19)
|
JCRB2219
|
human chromosome-introduced
|
human monochromosomal hybrid panel
|
contains human chromosome #19
|
A9(Neo2)
|
JCRB2202
|
human chromosome-introduced
|
human monochromosomal hybrid panel
|
contains human chromosome # 2
|
A9(Neo20)
|
JCRB2220
|
human chromosome-introduced
|
human monochromosomal hybrid panel
|
contains human chromosome #20
|
A9(Neo3)
|
JCRB2203
|
human chromosome-introduced
|
human monochromosomal hybrid panel
|
contains human chromosome # 3
|
A9(Neo4)
|
JCRB2204
|
human chromosome-introduced
|
human monochromosomal hybrid panel
|
contains human chromosome # 4
|
A9(Neo5)
|
JCRB2205
|
human chromosome-introduced
|
human monochromosomal hybrid panel
|
contains human chromosome # 5
|
A9(Neo6)
|
JCRB2206
|
human chromosome-introduced
|
human monochromosomal hybrid panel
|
contains human chromosome # 6
|
A9(Neo7)
|
JCRB2207
|
human chromosome-introduced
|
human monochromosomal hybrid panel
|
contains human chromosome # 7
|
A9(Neo8)
|
JCRB2208
|
human chromosome-introduced
|
human monochromosomal hybrid panel
|
contains human chromosome # 8
|
A9(NTI8)-2
|
JCRB0726
|
human chromosome-introduced
|
human chromosomal hybrid
|
contains human chromosome # 7
|
ABC-1
|
JCRB0815
|
human
|
lung (cancer)
|
adenocarcinoma
|
Ac2F
|
JCRB0408
|
rat
|
liver
|
normal liver, diploid, (Donryu rat)
|
Ac2F(DT)
|
JCRB0416
|
rat
|
liver
|
Ac2F-derived, 3'-methyl-4-dimethylaminoazobenzene transformed, (Donryu rat)
|
Ac2F(ST)
|
JCRB0417
|
rat
|
liver
|
Ac2F-derived, spontaneously transformed, (Donryu rat)
|
Ad12-3Y1-Z19
|
JCRB0737
|
rat
|
embryo
|
3Y1 derivative, Ad12-transformed, (Fischer rat)
|
AH601(JTC27)
|
JCRB0132.1
|
rat
|
liver
|
transplantable ascites hepatoma, (Donryu rat)
|
AH601.P3(JTC27)
|
JCRB0132.2
|
rat
|
liver
|
transplantable ascites hepatoma, serum-free, (Donryu rat)
|
AH601.P3(JTC27)
|
JCRB0132.3
|
rat
|
liver
|
transplantable ascites hepatoma, serum-free, direct deposition by original developer. (Donryu rat)
|
AH66tc
|
JCRB0411
|
rat
|
liver
|
ascites hepatoma, (Donryu rat)
|
AH70Btc
|
JCRB0412
|
rat
|
liver
|
ascites hepatoma, (Donryu rat)
|
AH-7974.P3
|
JCRB0714.1
|
rat
|
liver
|
ascites hepatoma, JTC-16 (AH-7974) derivative, serum-free, deposited by original developer, (Donryu rat)
|
AIG
|
JCRB1105
|
hamster, Chinese
|
lung
|
anchorage-independent mutant of CHL
|
Alexander cells
|
IFO50069
|
human
|
liver, gallbladder
|
hepatoma, HBs antigen-positive
|
AM-38
|
IFO50492
|
human
|
neural
|
glioblastoma, GFAP and S-100-positive, ACNU(a cancer chemotherapy drug)-sensitive
|
AP-16
|
IFO50424
|
mouse
|
neural
|
astrocyte-progenitor cell line, (C3H/He mouse)
|
AR-EcoScreen
|
JCRB1328
|
hamster, Chinese
|
ovary
|
androgen receptor-luciferase reporter gene introduced CHO for reporter assay of androgen (MTA to developer is required)
|
ARLJ301-3
|
JCRB0248
|
rat
|
liver
|
liver epithelial cell, (F344/DuCrj rat)
|
ASF-4-1
|
IFO50418
|
human
|
skin
|
skin, normal diploid fibroblast
|
ASF-4-2
|
IFO50419
|
human
|
skin
|
skin, normal diploid fibroblast
|
ASH-3
|
JCRB1073
|
human
|
thyroid
|
thyroid anaplastic carcinoma
|
AT(L)5KY
|
JCRB0331
|
human
|
hemo-lymphocytic
|
EBV transformed B lymphoblastoid cell line, ataxia telangiectasia
|
AT(L)6KY
|
JCRB0332
|
human
|
hemo-lymphocytic
|
EBV transformed B lymphoblastoid cell line, ataxia telangiectasia
|
AT(L)7KY
|
JCRB0333
|
human
|
hemo-lymphocytic
|
EBV transformed B lymphoblastoid cell line, ataxia telangiectasia
|
AT1OS
|
JCRB0308
|
human
|
skin
|
ataxia telangiectasia, fibroblast
|
AT2KY
|
JCRB0316
|
human
|
skin
|
ataxia telangiectasia, fibroblast
|
AtT-20
|
JCRB9098
|
mouse
|
pituitary
|
pituitary tumor, ACTH producing, (LAF1 mouse)
|
AZ-521
|
JCRB0061
|
human
|
stomach
|
originally established as gastric cancer-derived cell line, but is revealed to be the derivative of duodenum carcinoma cell line HuTu 80
|
B
|
Page Top
|
|
|
|
B-1
|
JCRB0243
|
mouse
|
testis
|
Leydig cell tumor, estrogen-dependent, (BALB/c mouse)
|
B104
|
JCRB0117
|
human
|
hemo-lymphocytic
|
lymphoma, malignant B lymphoma
|
B104-R3
|
JCRB0117.1
|
human
|
hemo-lymphocytic
|
lymphoma, malignant B lymphoma, anti-IgM antibody resistant B104
|
B16 melanoma
|
JCRB0202
|
mouse
|
melanoma
|
melanoma, skin, melanin pigment production (but large portion of cells is amelanotic)., (C57BL/6 mouse)
|
B2-17
|
IFO50361
|
human
|
neural
|
astrocytoma, thymidine kinase-deficient mutant of U251 MG cells
|
B8/3
|
JCRB0238
|
mouse
|
hemo-lymphocytic
|
erythroleukemia
|
B82
|
JCRB0212
|
mouse
|
skin
|
skin fibroblast, bromodeoxyuridine-resistant
|
B95-8
|
JCRB9123
|
cotten-top tamarin
|
hemo-lymphocytic
|
EBV transformed, release EBV infectious to primates
|
BALB/3T3 A31-1-1
|
JCRB0601
|
mouse
|
embryo
|
fibroblast, contact inhibited, (BALB/c mouse)
|
BALB/3T3 clone A31
|
JCRB9005
|
mouse
|
embryo
|
fibroblast, contact inhibited, (BALB/c mouse)
|
Balb/3T3-A31-1-1
|
IFO50070
|
mouse
|
embryo
|
fibroblast, subclone of Balb/3T3-A31, (BALB/c mouse)
|
Balb/c 3T3 A31-1-13
|
IFO50299
|
mouse
|
embryo
|
fibroblast, subclone of Balb/3T3 A31, (BALB/c mouse)
|
Balb/c 3T3 A31-I-1
|
IFO50298
|
mouse
|
embryo
|
fibroblast, subclone of Balb/3T3 A31, (BALB/c mouse)
|
BALB-MC
|
JCRB0233.0
|
mouse
|
mammary
|
mammary cancer, (BALB/cHe mouse)
|
BALB-MC.D3
|
JCRB0233.1
|
mouse
|
mammary
|
mammary cancer, (BALB/cHe mouse)
|
BALB-MC.E12
|
JCRB0233.2
|
mouse
|
mammary
|
mammary cancer, (BALB/cHe mouse)
|
BALL-1
|
JCRB0071
|
human
|
hemo-lymphocytic
|
leukemia, acute lymphoblastoid
|
BCE C/D-1b
|
JCRB9129
|
bovine
|
cornea
|
normal corneal epithelial cell, production of extracellular matrix proteins
|
BCL1 Clone CW13.20
|
JCRB9117
|
mouse
|
hemo-lymphocytic
|
leukemia, B cell, (BALB/c mouse)
|
BCNS1KO
|
JCRB0324
|
human
|
skin
|
basal cell nevus syndrome, fibroblasts
|
Becker
|
IFO50289
|
human
|
neural
|
astrocytoma, GFAP-negative
|
BeWo
|
JCRB9111
|
human
|
placenta
|
chorio carcinoma, trophoblastic cell line
|
Bhas 42
|
JCRB0149
|
mouse
|
embryo
|
H-ras transfected BALB 3T3 A31-1-1, (BALB/c mouse)
|
BHK-21(C-13)
|
JCRB9020
|
hamster, Syrian
|
kidney
|
kidney, subclone of BHK-21
|
BOKU
|
IFO50323
|
human
|
uterine cervix
|
cervical squamous cell carcinoma
|
BRL-3A
|
JCRB0025
|
rat
|
liver
|
MSA (somatomedin-like) protein producing, (Buffalo rat)
|
BRL-3A
|
JCRB9114
|
rat
|
liver
|
MSA (somatomedin-like) protein producing, (Buffalo rat)
|
BS2CH
|
JCRB0317
|
human
|
skin
|
Bloom's syndrome, fibroblast
|
BS2CHTERT
|
JCRB1061
|
human
|
skin
|
Bloom's syndrome, fibroblast, immortalized by hTERT
|
BS-C-1
|
IFO50413
|
monkey, African green
|
kidney
|
suitable host for transfection experiments of SV40 vectors
|
BS-C-1
|
JCRB9011
|
monkey, African green
|
kidney
|
kidney
|
BS-C-1
|
JCRB9126
|
monkey, African green
|
kidney
|
suitable host for transfection experiments of SV40 vectors
|
BSL2KA
|
JCRB1042
|
human
|
hemo-lymphocytic
|
EBV transformed B lymphoblastoid cell line from Bloom's syndrome patient
|
BW5147.G.1.4.OUA-R.1
|
JCRB9002
|
mouse
|
hemo-lymphocytic
|
lymphoma, T cell lymphoma, (AKR/J mouse)
|
C
|
Page Top
|
|
|
|
C32TG
|
JCRB0227
|
human
|
melanoma
|
skin amelanotic melanoma, 6-thioguanine-resistant
|
C3H/10T1/2 clone 8
|
JCRB0602
|
mouse
|
embryo
|
fibroblast, contact inhibited, (C3H mouse)(Now not available. Please use JCRB0003.)
|
C3H/10T1/2 clone 8
|
JCRB9080
|
mouse
|
embryo
|
fibroblast, contact inhibited, (C3H mouse)
|
C3H/10T1/2-clone 8
|
JCRB0003
|
mouse
|
embryo
|
fibroblast, contact inhibited, (C3H mouse)
|
C3H/10T1/2-clone8
|
IFO50415
|
mouse
|
embryo
|
fibroblast, contact inhibited, (C3H mouse)
|
C3H/MCA clone 15
|
IFO50042
|
mouse
|
embryo
|
3-methylcholanthrene-transformed C3H/10T1/2, (C3H mouse)
|
C6
|
IFO50110
|
rat
|
neural
|
glial tumor, GFAP-positive
|
C6
|
JCRB9096
|
rat
|
neural
|
glial tumor, GFAP-positive
|
C6/36
|
IFO50010
|
mosquito
|
hatched larvae
|
useful for replication of flavivirus
|
C6-SF2
|
IFO50425
|
rat
|
neural
|
C6 subline adapted to serum-free medium
|
Ca Ski
|
IFO50007
|
human
|
uterine cervix
|
cervical epidermoid cancer
|
Ca9-22
|
JCRB0625
|
human
|
oral
|
squamous carcinoma, gingiva
|
Caki-1
|
JCRB0801
|
human
|
kidney
|
renal clear cell carcinoma
|
CaR-1
|
JCRB0207
|
human
|
rectum
|
adenocarcinoma
|
CCD 841 CoN
|
IFO50482
|
human
|
colon
|
established from normal colonic tissue, epithelial-like, (distribution finished)
|
CCD-14Br
|
JCRB9101
|
human
|
lung
|
bronchus, diploid
|
CCD-33Co
|
IFO50483
|
human
|
colon
|
established from normal colon, fibroblast, (the lot in cellbank does not grow)
|
CCK-81
|
JCRB0208
|
human
|
colon
|
adenocarcinoma
|
CCRF S-180 II
|
JCRB9089
|
mouse
|
sarcoma
|
S-180 sarcoma derivative
|
CCRF-CEM
|
IFO50412
|
human
|
hemo-lymphocytic
|
leukemia, acute T lymphoblastic
|
CCRF-CEM
|
JCRB0033
|
human
|
hemo-lymphocytic
|
leukemia, acute T lymphoblastic
|
CCRF-CEM
|
JCRB9023
|
human
|
hemo-lymphocytic
|
leukemia, acute T lymphoblastic
|
CCRF-HSB2
|
JCRB0031
|
human
|
hemo-lymphocytic
|
leukemia, acute T lymphoblastic
|
CCRF-SB
|
IFO50026
|
human
|
hemo-lymphocytic
|
leukemia, acute B lymphoblastic
|
CCRF-SB
|
JCRB0032
|
human
|
hemo-lymphocytic
|
leukemia, acute B lymphoblastic
|
Ch 1 Es
|
JCRB9037
|
goat
|
esophagus
|
esophagus
|
Chang Liver
|
IFO50016
|
human
|
HeLa-contaminant
|
originally established from liver, HeLa-contaminated
|
Chang Liver
|
JCRB9066
|
human
|
HeLa-contaminant
|
originally established from liver, HeLa-contaminated
|
CHL/IU
|
JCRB0030
|
hamster, Chinese
|
lung
|
normal
|
CHO(His9)
|
JCRB2209
|
human chromosome-introduced
|
human monochromosomal hybrid panel
|
contains human chromosome # 9
|
CHO(pMAM-HSluc)
|
JCRB0136.2
|
hamster, Chinese
|
ovary
|
pMAM-HSluc transfected CHO-K1, HSP 70B gene promoter and luciferase reporter gene introduced
|
CHO(pMAM-luc)
|
JCRB0136.1
|
hamster, Chinese
|
ovary
|
pMAM-luc transfected CHO-K1, luciferase activated by dexamethasone
|
CHO/HGPRT
|
JCRB0218
|
hamster, Chinese
|
ovary
|
HPRT-deficient CHO cell line
|
CHO-K1
|
IFO50414
|
hamster, Chinese
|
ovary
|
subclone of CHO (Chainese hamster ovary) cells
|
CHO-K1
|
JCRB9018
|
hamster, Chinese
|
ovary
|
subclone of CHO (Chainese hamster ovary) cells
|
CKT-1
|
IFO50003
|
bovine
|
kidney
|
useful to assay bovine adenovirus 3
|
CKT-1
|
JCRB0008
|
bovine
|
kidney
|
useful to assay bovine adenovirus 3
|
CMK-11-5
|
IFO50430
|
human
|
hemo-lymphocytic
|
leukemia, acute megakaryoblastic
|
CMK-86
|
IFO50428
|
human
|
hemo-lymphocytic
|
leukemia, acute megakaryoblastic
|
CoCM-1
|
JCRB0257
|
human
|
colon
|
adenocarcinoma
|
COLO201
|
JCRB0226
|
human
|
colon
|
adenocarcinoma
|
COLO320 DM
|
JCRB0225
|
human
|
colon
|
adenocarcinoma
|
COS-1
|
JCRB9082
|
monkey, African green
|
kidney
|
SV40 transformed African green monkey kidney
|
COS-7
|
IFO50068
|
monkey, African green
|
kidney
|
transformant of CV-1 cells by origin-defective SV-40, SV-40 large T antigen-expressing
|
COS-7
|
JCRB9127
|
monkey, African green
|
kidney
|
transformant of CV-1 cells by origin-defective SV-40, SV-40 large T antigen-expressing
|
CPA
|
IFO50272
|
bovine
|
vascular system
|
pulmonary artery normal endothelial cell
|
CPA
|
JCRB9025
|
bovine
|
vascular system
|
pulmonary artery normal endothelial cell
|
CPAE
|
JCRB9022
|
bovine
|
vascular system
|
pulmonary artery normal endothelial cell
|
CPT-K5
|
JCRB1067
|
human
|
hemo-lymphocytic
|
leukemia, acute lymphoblastic, camptothecin-resistant mutant of RPMI8402
|
CRFK
|
JCRB9035
|
cat
|
kidney
|
kidney, BVD antigen negative
|
cs-17-25
|
JCRB1102
|
hamster, Chinese
|
lung
|
cold-sensitive anchorage-independent growth mutant of CHL
|
cs-19-36
|
JCRB1103
|
hamster, Chinese
|
lung
|
cold-sensitive anchorage-independent growth mutant of CHL
|
cs-20-5
|
JCRB1104
|
hamster, Chinese
|
lung
|
cold-sensitive anchorage-independent growth mutant of CHL
|
CS2AW
|
JCRB0310
|
human
|
skin
|
Cockayne's syndrome, fibroblast
|
CS2AWTERT
|
JCRB1059
|
human
|
skin
|
Cockayne's syndrome, fibroblast, immortalized by hTERT
|
CS2OS
|
JCRB0309
|
human
|
skin
|
Cockayne's syndrome, fibroblast
|
CS2OS(SVT)
|
JCRB1056
|
human
|
skin
|
Cockayne's syndrome, fibroblast, immortalized by SV40 large T
|
CV-1
|
JCRB9049
|
monkey, African green
|
kidney
|
kidney, highly susceptible to SV40 infection
|
c-WRT-7-LR
|
JCRB0168
|
rat
|
hemo-lymphocytic
|
RLV infected myelomonocytic leukemia.
|
D
|
Page Top
|
|
|
|
D422T
|
JCRB9112
|
human
|
sarcoma
|
benign abdominal desmoid tumor
|
Daudi
|
JCRB9071
|
human
|
hemo-lymphocytic
|
lymphoma, Burkitt's
|
DBC1.2
|
IFO50484
|
mouse
|
olfactory epithelium
|
dark (horizontal) basal cell-like, keratin-positive, (C3H/He mouse)
|
DD-762
|
JCRB1077
|
mouse
|
mammary
|
mammary tumor, producing MuMTV, (DD/Tbr mouse)
|
De Gin
|
JCRB9078
|
human
|
skin
|
osteoporosis, skin
|
delta-47
|
JCRB1344
|
human
|
hemo-lymphocytic
|
myeloma, secreting IgD
|
Dempsey
|
JCRB9088
|
human
|
skin
|
Klinefelter's syndrome, skin
|
Detroit 510
|
JCRB9104
|
human
|
skin
|
galactosemia, skin
|
Detroit 525
|
JCRB9102
|
human
|
skin
|
Turner's syndrome, skin
|
Detroit 529
|
JCRB9043
|
human
|
skin
|
Down's syndrome, skin
|
Detroit 532
|
JCRB9044
|
human
|
skin
|
Down's syndrome, foreskin
|
Detroit 539
|
JCRB9045
|
human
|
skin
|
Down's syndrome, skin
|
DIG104.10H.1
|
JCRB1213.3
|
mouse
|
antibody-producing hybridoma
|
anti-digoxin antibody, subclass IgG1(k)
|
DIG222.4D.5
|
JCRB1213.2
|
mouse
|
antibody-producing hybridoma
|
anti-digoxin antibody, subclass IgG2b(k)
|
DL-40
|
JCRB1337
|
human
|
hemo-lymphocytic
|
lymphoma, non-Hodikin's, Ki-1-positive
|
DLD-1
|
JCRB9094
|
human
|
colon
|
adenocarcinoma
|
dRLa-74 Clone 2
|
JCRB0409
|
rat
|
liver
|
liver adenoma, (Donryu rat)
|
dRLh-84
|
JCRB0410
|
rat
|
liver
|
hepatoma, (Donryu rat)
|
dRLN-4
|
JCRB0418
|
rat
|
liver
|
liver cell line, 3'-methyl-4-dimethylaminoazobenzene induced, (Donryu rat)
|
dRLN-6
|
JCRB0420
|
rat
|
liver
|
liver cell line, 3'-methyl-4-dimethylaminoazobenzene induced, (Donryu rat)
|
dRLN-9
|
JCRB0419
|
rat
|
liver
|
liver cell line, 3'-methyl-4-dimethylaminoazobenzene induced, (Donryu rat)
|
DSPT200
|
JCRB0217
|
hamster, Syrian
|
embryo
|
fetus fibroblast transformed cell
|
DT40
|
JCRB9130
|
chicken
|
hemo-lymphocytic
|
avian leukosis virus (ALV)-induced lymphomas
|
E
|
Page Top
|
|
|
|
E1A-3Y1-1
|
JCRB0738
|
rat
|
embryo
|
3Y1 derivative, transformed by E1A of Ad12 virus, (Fischer rat)
|
EB-3
|
IFO50028
|
human
|
hemo-lymphocytic
|
eliminated from catalog (IFO50028 EB-3 revealed to be the same as Daudi cell line)
|
EBC-1
|
JCRB0820
|
human
|
lung (cancer)
|
squamous cell carcinoma
|
EBTr (NBL-4)
|
JCRB9038
|
bovine
|
lung
|
embryonic trachea
|
ECV304
|
JCRB0744
|
human
|
vascular system
|
immortalized normal endothelium, contamination by T-24/EJ1 was suspected.
|
EGV-4T
|
JCRB0229
|
rat
|
lung
|
immortal cell line from MNNG-transformed tracheal epithelial cells
|
Ehrlich ascites
|
JCRB9090
|
mouse
|
ascites
|
Ehrlich-Lettre ascites carcinoma
|
EHS
|
IFO50268
|
mouse
|
sarcoma
|
chondrosarcoma, secreting basement membrane matrix, (ST/Eh mouse)
|
EJ-1
|
JCRB0710
|
human
|
bladder
|
bladder carcinoma, contamination by T24 cells has been suspected
|
Ex-3LL
|
JCRB1349
|
mouse
|
lung
|
Lewis lung cancer-derived. Enhanced lung metastasis ability. (C57BL mouse)
|
F
|
Page Top
|
|
|
|
F119
|
JCRB1324
|
mouse
|
antibody-producing hybridoma
|
anti-CD307 (IRTA2/FcRH5/FCRL5), IgG2b
|
F2408
|
IFO50015
|
rat
|
embryo
|
fibroblast-like, (Fischer rat)
|
F2408 EBNA2 cl-14
|
JCRB0143.5
|
rat
|
embryo
|
EBNA2-transfected, (Fischer rat)
|
F2408 EBNA2 cl-16
|
JCRB0143.2
|
rat
|
embryo
|
EBNA2-transfected, (Fischer rat)
|
F2408 EBNA2 cl-18
|
JCRB0143.3
|
rat
|
embryo
|
EBNA2-transfected, (Fischer rat)
|
F2408 EBNA2 cl-23
|
JCRB0143.6
|
rat
|
embryo
|
EBNA2-transfected, (Fischer rat)
|
F2408 EBNA2 cl-24
|
JCRB0143.4
|
rat
|
embryo
|
EBNA2-transfected, (Fischer rat)
|
F2408 EBNA2 cl-28
|
JCRB0143.7
|
rat
|
embryo
|
EBNA2-transfected, (Fischer rat)
|
F2408 EBNA2 cl-9
|
JCRB0143.1
|
rat
|
embryo
|
EBNA2-transfected, (Fischer rat)
|
F2408 pZipNeo
|
JCRB0143.0
|
rat
|
embryo
|
pZipNeo-transfected, control for F2408 EBNA2 clones, (Fischer rat)
|
F2408-B812
|
IFO50099
|
rat
|
embryo
|
HGPRT(-), TS for transformation by Moloney MSV, (Fischer rat)
|
F2408-B993
|
IFO50100
|
rat
|
embryo
|
HGPRT(-), TS for transformation by Moloney MSV, (Fischer rat)
|
F2408-No.20
|
IFO50101
|
rat
|
embryo
|
thymidine kinase-deficient F2408 cell line, (Fischer rat)
|
F2408-No.3
|
IFO50098
|
rat
|
embryo
|
HGPRT-deficient F2408 cell line, (Fischer rat)
|
F2408-No.7
|
IFO50102
|
rat
|
embryo
|
HGPRT-deficient F2408 cell line, (Fischer rat)
|
F25
|
JCRB1323
|
mouse
|
antibody-producing hybridoma
|
anti-CD307 (IRTA2/FcRH5/FCRL5), IgG2a
|
F56
|
JCRB1189
|
mouse
|
antibody-producing hybridoma
|
anti-CD307 (IRTA2/FcRH5/FCRL5), IgG1
|
F9
|
JCRB0721
|
mouse
|
teratoma
|
teratocarcinoma, differentiation-inducible, (129/Sv mouse)
|
F9-41
|
JCRB0001
|
mouse
|
teratoma
|
teratocarcinoma, differentiation-inducible, (129/Sv mouse)
|
FA18JTO
|
JCRB0315
|
human
|
skin
|
Fanconi's anemia, fibroblast
|
FA9JTO
|
JCRB0314
|
human
|
skin
|
Fanconi's anemia, fibroblast
|
FA9JTOTERT
|
JCRB1060
|
human
|
skin
|
Fanconi's anemia, fibroblast, immortalized by hTERT
|
FAA-HTC1
|
JCRB0249
|
rat
|
liver
|
hepatocellular carcinoma, 2-acetylaminofluorene induced, (F344/DuCrj rat)
|
FBHE
|
IFO50154
|
bovine
|
vascular system
|
heart normal endothelial cell, FGF-dependent for survival
|
FF101
|
JCRB1040
|
rat
|
liver
|
hepatoma, 3'-methyl-4-dimethylaminoazobenzene-induced, serum-free, (Donryu rat)
|
FHs 74 Int
|
JCRB9076
|
human
|
intestine
|
fetal small intestine, normal, (not intestinal epithelial cell)
|
FL*
|
JCRB9016
|
human
|
HeLa-contaminant
|
originally established from amnion, HeLa-contaminated
|
FLAM-76
|
JCRB1346
|
human
|
hemo-lymphocytic
|
myeloma, IL-6-dependent, growth is very slow
|
Flow2000
|
IFO50089
|
human
|
lung
|
fetal lung, normal diploid fibroblast
|
Flow2000
|
JCRB0067
|
human
|
lung
|
fetal lung, normal diploid fibroblast (not available)
|
Flow3000
|
JCRB0068
|
human
|
neural
|
normal fibroblast
|
Flow7000
|
IFO50079
|
human
|
skin
|
skin, normal diploid fibroblast
|
FLS3
|
IFO50377
|
mouse
|
liver
|
liver stromal cell line
|
FLS5
|
IFO50378
|
mouse
|
liver
|
liver stromal cell line
|
FM3A
|
JCRB0701
|
mouse
|
mammary
|
mammary carcinoma, spontaneously obtained, (C3H/He mouse)
|
FM3A APRT~
|
JCRB0703
|
mouse
|
mammary
|
mammary carcinoma, APRT-deficient FM3A, (C3H/He mouse)
|
FM3A HPRT~
|
JCRB0702
|
mouse
|
mammary
|
mammary carcinoma, HPRT-deficient FM3A , (C3H/He mouse)
|
FM3A TK~
|
JCRB0704
|
mouse
|
mammary
|
mammary carcinoma, thymidine kinase-deficient FM3A, (C3H/He mouse)
|
FPC15JTO
|
JCRB0319
|
human
|
skin
|
familial polyposis coli, fibroblasts
|
FPC5JTO
|
JCRB0318
|
human
|
skin
|
familial polyposis coli, fibroblasts
|
FRSK
|
JCRB0005
|
rat
|
skin
|
epidermal keratinocyte line from fetal skin
|
FS-1
|
IFO50477
|
human
|
bone marrow stroma
|
bone marrow stromal cell from a myelogenous leukemia patient
|
FSthy21
|
JCRB0719
|
mouse
|
thymidylate defective
|
complete defective strain of thymidylate synthase, (C3H mouse)
|
FU97
|
JCRB1074
|
human
|
stomach
|
adenocarcinoma, poorly differentiated, AFP producing
|
G
|
Page Top
|
|
|
|
G-292 clone A141B1
|
IFO50107
|
human
|
sarcoma
|
osteosarcoma
|
G-361
|
IFO50009
|
human
|
melanoma
|
malignant melanoma, skin
|
G-361
|
JCRB9074
|
human
|
melanoma
|
malignant melanoma, skin
|
G-401
|
JCRB9065
|
human
|
kidney
|
Wilms' tumor (embryonal carcinosarcoma of kidney)
|
G-402
|
JCRB9070
|
human
|
kidney
|
renal leiomyoblastoma
|
GAK
|
IFO50321
|
human
|
melanoma
|
malignant melanoma at external genitalia, metastasis to lymph node
|
GAK
|
JCRB0180
|
human
|
melanoma
|
malignant melanoma at external genitalia, metastasis to lymph node
|
GB-1
|
IFO50489
|
human
|
neural
|
glioma, GFAP, vimentin and fibronectin-positive
|
GCH-nu-YS
|
JCRB1201
|
human
|
uterus
|
gestational uterine choriocarcinoma
|
GH1
|
IFO50269
|
rat
|
pituitary
|
pituitary tumor, somatotrophin-secreting, (Wistar/Furth rat)
|
GH1
|
JCRB9046
|
rat
|
pituitary
|
pituitary tumor, somatotrophin-secreting, (Wistar/Furth rat)
|
GH3
|
IFO50105
|
rat
|
pituitary
|
pituitary tumor, somatotrophin and prolactin-secreting, (Wistar/Furth rat)
|
GH3
|
JCRB9047
|
rat
|
pituitary
|
pituitary tumor, somatotrophin and prolactin-secreting, (Wistar/Furth rat)
|
GHBP116
|
JCRB1226
|
mouse
|
antibody-producing hybridoma
|
anti-human growth hormone receptor antibody-producing, subclass IgG1(k)
|
GOTO
|
JCRB0612
|
human
|
neural
|
neuroblastoma, adrenal gland
|
GOTO.P3
|
JCRB0612.1
|
human
|
neural
|
neuroblastoma, adrenal gland, serum-free
|
GP-1
|
JCRB1366
|
guinea pig
|
hemo-lymphocytic
|
Guinea pig leukocyte line co-infected with HTLV-I and HTLV-II. (This cell line is supplied from National Institute of Biomedical Innovation.)
|
GP8
|
JCRB1198
|
mouse
|
skin
|
human beta-galactosidase gene introduced fibroblast (background, C57BL/6 beta-galactosidase KO mouse-derived SV cells)
|
GRSL
|
IFO50111
|
mouse
|
hemo-lymphocytic
|
thymic leukemia, (GR/A mouse)
|
GS33JTO
|
JCRB0322
|
human
|
skin
|
Gardner's syndrome, fibroblasts, (M)
|
GS7OJTO
|
JCRB0323
|
human
|
skin
|
Gardner's syndrome, fibroblasts
|
H
|
Page Top
|
|
|
|
HARA
|
JCRB1080.0
|
human
|
lung (cancer)
|
squamous carcinoma, PTHrP producing
|
HARA-B
|
JCRB1080.1
|
human
|
lung (cancer)
|
squamous carcinoma, PTHrP producing, established from nude mouse bone metastasis of HARA cells
|
HCA-1
|
JCRB1153
|
human
|
uterine cervix
|
endocervical adenocarcinoma endocervical adenocarcinoma cell line.
|
HCC-56
|
JCRB1037
|
human
|
colon
|
adenocarcinoma, moderately differentiated
|
HCS-2
|
JCRB1203
|
human
|
uterine cervix
|
cervical squamous cell carcinoma
|
HCSC-1
|
JCRB1205
|
human
|
uterine cervix
|
endocervical small cell carcinoma
|
HCT-2
|
JCRB1362
|
hamster, Syrian
|
hemo-lymphocytic
|
Hamster spleen lymphocytes transformed by HTLV-I (This cell line is supplied from National Institute of Biomedical Innovation).
|
HD-70
|
JCRB1335
|
human
|
hemo-lymphocytic
|
lymphoma, from Hodgkin's
|
HE-1
|
IFO50297
|
human
|
embryo
|
whole fetus, normal diploid fibroblast
|
HEC-1
|
JCRB0042
|
human
|
uterus
|
endometrial adenocarcinoma
|
HEC-108
|
JCRB1123
|
human
|
uterus
|
endometrial adenocarcinoma
|
HEC-116
|
JCRB1124
|
human
|
uterus
|
endometrial adenocarcinoma
|
HEC-151
|
JCRB1122
|
human
|
uterus
|
endometrial adenocarcinoma
|
HEC-155
|
JCRB1127
|
human
|
uterus
|
endometrial adenocarcinoma, (distribution was suspended)
|
HEC-1-A
|
JCRB1117
|
human
|
uterus
|
endometrial adenocarcinoma
|
HEC-1-B
|
JCRB1193
|
human
|
uterus
|
endometrial adenocarcinoma
|
HEC-251
|
JCRB1141
|
human
|
uterus
|
endometrial adenocarcinoma
|
HEC-265
|
JCRB1142
|
human
|
uterus
|
endometrial adenocarcinoma
|
HEC-50B
|
JCRB1145
|
human
|
uterus
|
endometrial adenocarcinoma
|
HEC-59
|
JCRB1120
|
human
|
uterus
|
endometrial adenocarcinoma
|
HEC-6
|
JCRB1118
|
human
|
uterus
|
endometrial adenocarcinoma
|
HEC-88nu
|
JCRB1121
|
human
|
uterus
|
endometrial adenocarcinoma
|
HEL
|
JCRB0062
|
human
|
hemo-lymphocytic
|
leukemia, erythroid
|
HeLa
|
JCRB9004
|
human
|
uterine cervix
|
epitheloid carcinoma
|
HeLa 229
|
JCRB9086
|
human
|
uterine cervix
|
epitheloid carcinoma
|
HeLa AG
|
JCRB0213
|
human
|
uterine cervix
|
epitheloid carcinoma, 8-azaguanine-resistant
|
HeLa S3
|
IFO50011
|
human
|
uterine cervix
|
cervical epithelioid carcinoma
|
HeLa S3
|
JCRB9010
|
human
|
uterine cervix
|
cervical epitheloid carcinoma, adaptable to a suspension culture
|
HeLa S3 (sc)
|
JCRB0713
|
human
|
uterine cervix
|
HeLa derivative, can grow in suspension culture
|
HeLa TG
|
JCRB0214
|
human
|
uterine cervix
|
epitheloid carcinoma, 6-thioguanine-resistant
|
HeLa TG Cap
|
JCRB0215
|
human
|
uterine cervix
|
epitheloid carcinoma, 6-thioguanine, chloramphenicol-resistant
|
HeLa.P3
|
JCRB0649
|
human
|
uterine cervix
|
serum free adapted HeLa cell line
|
HeLa.P3
|
JCRB0649.1
|
human
|
uterine cervix
|
serum free adapted HeLa cell line, deposited by original developer
|
HeLa.P3(S)
|
JCRB0606
|
human
|
uterine cervix
|
HeLa cell derived, can grow in a serum-free medium
|
HeLa9903
|
JCRB1318
|
human
|
uterine cervix
|
hERalpha-HeLa-9903, transfected with estrogen receptor-alpha - reporter gene construct. (MTA to developer is required)
|
Hep G2
|
JCRB1054
|
human
|
liver, gallbladder
|
hepatoma
|
HEPM
|
JCRB9095
|
human
|
oral
|
embryonic palatal mesenchyme, limited life span
|
HFb16d
|
JCRB1008
|
human
|
skin
|
normal fibroblast transfected with HPV16
|
HFL1
|
IFO50074
|
human
|
lung
|
fetal lung, normal diploid fibroblast
|
HGH1.1.3
|
JCRB1222.01
|
mouse
|
antibody-producing hybridoma
|
anti-human growth hormone antibody, subclass IgG1(k)
|
HGH1.11.1
|
JCRB1222.08
|
mouse
|
antibody-producing hybridoma
|
anti-human growth hormone antibody, subclass IgG2b(k)
|
HGH1.15.3
|
JCRB1222.09
|
mouse
|
antibody-producing hybridoma
|
anti-human growth hormone antibody, subclass IgG1(k)
|
HGH1.17.2
|
JCRB1222.03
|
mouse
|
antibody-producing hybridoma
|
anti-human growth hormone antibody, subclass IgG1(k)
|
HGH1.31.3
|
JCRB1222.12
|
mouse
|
antibody-producing hybridoma
|
anti-human growth hormone antibody, subclass IgG1(k)
|
HGH1.32.4
|
JCRB1222.13
|
mouse
|
antibody-producing hybridoma
|
anti-human growth hormone antibody, subclass IgG2b(k)
|
HGH1.35.2
|
JCRB1222.04
|
mouse
|
antibody-producing hybridoma
|
anti-human growth hormone antibody, subclass IgG2a(k)
|
HGH1.41.1
|
JCRB1222.10
|
mouse
|
antibody-producing hybridoma
|
anti-human growth hormone antibody, subclass IgG2b(k)
|
HGH1.46.1
|
JCRB1222.11
|
mouse
|
antibody-producing hybridoma
|
anti-human growth hormone antibody, subclass IgG2b(k)
|
HGH1.6.5
|
JCRB1222.02
|
mouse
|
antibody-producing hybridoma
|
anti-human growth hormone antibody, subclass IgG1(k)
|
HGH1.8.1
|
JCRB1222.07
|
mouse
|
antibody-producing hybridoma
|
anti-human growth hormone antibody, subclass IgG2b(k)
|
HGH1.9.3
|
JCRB1222.06
|
mouse
|
antibody-producing hybridoma
|
anti-human growth hormone antibody, subclass IgG1(k)
|
HGH2.15.4
|
JCRB1222.16
|
mouse
|
antibody-producing hybridoma
|
anti-human growth hormone antibody, subclass IgG1(lambda)
|
HGH2.4.2
|
JCRB1222.15
|
mouse
|
antibody-producing hybridoma
|
anti-human growth hormone antibody, subclass IgG1(k)
|
HGH2.6.1
|
JCRB1222.05
|
mouse
|
antibody-producing hybridoma
|
anti-human growth hormone antibody, subclass IgG1(k)
|
HH
|
JCRB0099
|
bovine
|
vascular system
|
carotid artery normal endothelial cell
|
HKA-1
|
JCRB1017
|
human
|
skin
|
giant keratoacanthoma
|
HL60
|
JCRB0085
|
human
|
hemo-lymphocytic
|
leukemia, acute promyelotic, differentiation-inducible
|
HL-60
|
IFO50022
|
human
|
hemo-lymphocytic
|
leukemia, acute promyelocytic, Ability for the differentiation by TPA or DMSO reduced
|
HL60(S)
|
JCRB0163
|
human
|
hemo-lymphocytic
|
leukemia, acute promyelotic
|
HL60RG
|
JCRB0006
|
human
|
hemo-lymphocytic
|
leukemia, acute promyelocytic, HL60-derived, equivalent to IFO50022, Ability for the differentiation by TPA or DMSO reduced
|
HLCL-1
|
JCRB0041
|
human
|
hemo-lymphocytic
|
lymphocyte, peripheral
|
HLE
|
JCRB0404
|
human
|
liver, gallbladder
|
hepatoma, non-differentiated
|
HLF
|
JCRB0405
|
human
|
liver, gallbladder
|
hepatoma, non-differentiated
|
HM-1
|
JCRB1208
|
hamster, Syrian
|
hemo-lymphocytic
|
macrophage line
|
HMC-1-8
|
JCRB0166
|
human
|
mammary
|
breast cancer, target cell of the T-cell killer clone T(cHMC-1)
|
HMY-1
|
JCRB1018
|
human
|
melanoma
|
malignant melanoma, sole, melanin production is poor
|
HO-1-N-1
|
JCRB0831
|
human
|
oral
|
squamous carcinoma, buccal mucosa
|
HO-1-u-1
|
JCRB0828
|
human
|
oral
|
squamous carcinoma, mouth floor
|
HOS
|
IFO50106
|
human
|
sarcoma
|
osteosarcoma
|
HPSV178-4-3
|
JCRB1314
|
mouse
|
antibody-producing hybridoma
|
HPSV178 antibody, against GPI-anchorless splice variant of prion protein
|
HR-3Y1-2
|
JCRB0743
|
rat
|
embryo
|
3Y1 derivative, transformed by v-H-ras cDNA, (Fischer rat)
|
hs-103-3
|
JCRB1096
|
hamster, Chinese
|
lung
|
heat-sensitive anchorage-independent growth mutant of CHL
|
hs-164-2
|
JCRB1097
|
hamster, Chinese
|
lung
|
heat-sensitive anchorage-independent growth mutant of CHL
|
hs-171-1
|
JCRB1098
|
hamster, Chinese
|
lung
|
heat-sensitive anchorage-independent growth mutant of CHL
|
hs-172-3
|
JCRB1099
|
hamster, Chinese
|
lung
|
heat-sensitive anchorage-independent growth mutant of CHL
|
hs-211
|
JCRB1100
|
hamster, Chinese
|
lung
|
heat-sensitive anchorage-independent growth mutant of CHL
|
HS-22
|
JCRB1215
|
mouse
|
bone marrow
|
mesenchymal stem cell line
|
hs-222-3
|
JCRB1101
|
hamster, Chinese
|
lung
|
heat-sensitive anchorage-independent growth mutant of CHL
|
Hs68
|
IFO50350
|
human
|
skin
|
skin, normal diploid fibroblast
|
HSC-1
|
JCRB1015
|
human
|
skin
|
squamous carcinoma
|
HSC-2
|
JCRB0622
|
human
|
oral
|
squamous carcinoma, mouth
|
HSC-3
|
JCRB0623
|
human
|
oral
|
squamous carcinoma, tongue
|
HSC-4
|
JCRB0624
|
human
|
oral
|
squamous carcinoma, tongue
|
HSC-5
|
JCRB1016
|
human
|
skin
|
squamous carcinoma
|
HSC-F
|
JCRB1164
|
monkey, Cynomolgus
|
hemo-lymphocytic
|
HSV-immortalized T-cell line, susceptible to SIV
|
HSGc-C5
|
JCRB1070
|
human
|
HeLa-contaminant
|
originally established from salivary gland, Hela-contaminated, used as a standardization for the heavy particle irradiation.
|
HSP-239
|
JCRB1165
|
chimpanzee
|
hemo-lymphocytic
|
peripheral blood lymphocyte line immortalized with Herpesvirus saimiri
|
HSP-250
|
JCRB1177
|
chimpanzee
|
hemo-lymphocytic
|
peripheral blood lymphocyte line immortalized with Herpesvirus saimiri
|
HSR-5
|
JCRB1211
|
monkey, rhesus
|
hemo-lymphocytic
|
peripheral blood lymphocyte line immortalized with Herpesvirus saimiri
|
HS-Sultan
|
JCRB9062
|
human
|
hemo-lymphocytic
|
established as plasmacytoma, but revealed as derivative of Jiyoye cell line (Burkitt's lymphoma)
|
HT100
|
JCRB0221
|
hamster, Syrian
|
lung
|
lung, new born
|
HT-1080
|
IFO50354
|
human
|
sarcoma
|
fibrosarcoma, acetabulum
|
HT-1080
|
JCRB9113
|
human
|
sarcoma
|
fibrosarcoma, acetabulum
|
HTC/C3
|
JCRB0164
|
human
|
thyroid
|
thyroid carcinoma
|
HuCCT1
|
JCRB0425
|
human
|
liver, gallbladder
|
bile duct carcinoma
|
huH-1
|
JCRB0199
|
human
|
liver, gallbladder
|
hepatoma, HBs antigen-positive, HBc(-), HBe(-).
|
HuH28
|
JCRB0426
|
human
|
liver, gallbladder
|
bile duct carcinoma
|
HUH-6 Clone 5
|
JCRB0401
|
human
|
liver, gallbladder
|
hepatoblastoma, well differentiated
|
HuH-7
|
JCRB0403
|
human
|
liver, gallbladder
|
hepatoma, differentiated
|
Human Mucosal cells
|
JCRB9116
|
human
|
colon
|
colon
|
HuO-3N1
|
JCRB0413
|
human
|
sarcoma
|
osteosarcoma, ilium
|
HuO9
|
JCRB0427
|
human
|
sarcoma
|
osteosarcoma
|
HuO9N2
|
JCRB0428
|
human
|
sarcoma
|
osteosarcoma
|
HUV-EC-C
|
IFO50271
|
human
|
vascular system
|
normal endothelial cell, umbilical cord
|
I
|
Page Top
|
|
|
|
I-10
|
JCRB9097
|
mouse
|
testis
|
Leydig cell testicular tumor (BALB/cJ mouse)
|
I51T
|
JCRB1225
|
mouse
|
skin
|
deficient human beta-gal introduced fibroblast (background, C57BL/6 beta-galactosidase KO mouse-derived SV cells)
|
IAR-20
|
JCRB0610
|
rat
|
liver
|
non-transformed live cell line, (BD-IV rat)
|
IHH-4
|
JCRB1079
|
human
|
thyroid
|
thyroid anaplastic carcinoma, (exhibits the same DNA profile as TMH-1.)
|
IM-9
|
IFO50025
|
human
|
hemo-lymphocytic
|
myeloma, multiple, B lymphoblastic
|
IM-9
|
JCRB0024
|
human
|
hemo-lymphocytic
|
myeloma, multiple, B lymphoblastic
|
IM95
|
JCRB1075.0
|
human
|
stomach
|
adenocarcinoma, moderately differentiated
|
IM95m
|
JCRB1075.1
|
human
|
stomach
|
adenocarcinoma, moderately differentiated, an IM95 clone producing higher level of HGF & VEGF
|
IMR-32
|
IFO50283
|
human
|
neural
|
neuroblastoma
|
IMR-32
|
JCRB9050
|
human
|
neural
|
neuroblastoma
|
IMR-90
|
JCRB0516
|
human
|
lung
|
fetal lung, normal diploid fibroblast
|
IMR-90
|
JCRB9054
|
human
|
lung
|
fetal lung, normal diploid fibroblast
|
IMR-90-40
|
JCRB0519
|
human
|
lung
|
fetal lung, normal diploid fibroblast, PDL=about 40
|
IMR-90-50
|
JCRB0520
|
human
|
lung
|
fetal lung, normal diploid fibroblast, PDL=about 50
|
Indian Muntjac
|
JCRB9100
|
Indian Muntjak
|
skin
|
used for chromosomal study
|
IT-26R21
|
IFO50078
|
rat
|
thymus
|
T cell differentiation factor producing, (Wistar rat)
|
IT-45R1
|
IFO50076
|
rat
|
thymus
|
T cell differentiation factor producing, (Wistar rat)
|
IT-45R91
|
IFO50077
|
rat
|
thymus
|
thymic fibroblast, (Wistar rat)
|
IT-79MTNC3
|
IFO50248
|
mouse
|
thymus
|
thymic nurse cell, (BALB/c mouse)
|
ITO-II
|
JCRB0613
|
human
|
testis
|
testicular tumor, (embryonal tumor)
|
J
|
Page Top
|
|
|
|
J-111
|
IFO50005
|
human
|
HeLa-contaminant
|
originally established from acute monocytic leukemia, HeLa-contaminated
|
J-111
|
JCRB0073
|
human
|
HeLa-contaminant
|
originally established from acute monocytic leukemia, HeLa-contaminated
|
J774.1
|
JCRB0018
|
mouse
|
hemo-lymphocytic
|
monocyte-macrophage, IL-1-producing, (BALB/c mouse)
|
J774A.1
|
JCRB9108
|
mouse
|
hemo-lymphocytic
|
monocyte-macrophage, (BALB/c mouse)
|
JHH-1
|
JCRB1062
|
human
|
liver, gallbladder
|
hepatoma
|
JHH-2
|
JCRB1028
|
human
|
liver, gallbladder
|
hepatoma
|
JHH-4
|
JCRB0435
|
human
|
liver, gallbladder
|
hepatoma
|
JHH-5
|
JCRB1029
|
human
|
liver, gallbladder
|
hepatoma
|
JHH-6
|
JCRB1030
|
human
|
liver, gallbladder
|
hepatoma
|
JHH-7
|
JCRB1031
|
human
|
liver, gallbladder
|
hepatoma, HBV-integration
|
JKT-beta-del
|
JCRB0147
|
human
|
hemo-lymphocytic
|
leukemia, T-cell, Jurkat cell clone with a lack of surface expression of T-cell receptor alpha/beta/CD3 complex
|
JTC-11
|
JCRB0424
|
mouse
|
ascites
|
Ehrlich ascites
|
JTC-16 P3
|
JCRB0714
|
rat
|
liver
|
ascites hepatoma, JTC-16 derivative, serum-free, (Donryu rat)
|
JTC19
|
JCRB0608
|
rat
|
lung
|
lung, (JAR-1 rat)
|
K
|
Page Top
|
|
|
|
K562
|
JCRB0019
|
human
|
hemo-lymphocytic
|
leukemia, chronic myelogenous, differentiation-inducible
|
K562/ADM
|
JCRB1002
|
human
|
hemo-lymphocytic
|
leukemia, chronic myelogenous, adriamycin resistant derivative of K562
|
KAI3
|
IFO50518
|
human
|
hemo-lymphocytic
|
EBV-infected NK-like cell line, IL-2 dependent
|
KALS-1
|
IFO50434
|
human
|
neural
|
glioma, GFAP, vimentin and CD13-positive
|
Kasumi-1
|
JCRB1003
|
human
|
hemo-lymphocytic
|
leukemia, acute myeloid
|
Kasumi-3
|
JCRB1004
|
human
|
hemo-lymphocytic
|
leukemia, acute myeloperoxidase-negative
|
Kasumi-6
|
JCRB1024
|
human
|
hemo-lymphocytic
|
leukemia, acute myeloid
|
KATOIII
|
JCRB0611
|
human
|
stomach
|
signet ring cell carcinoma
|
KB
|
JCRB9027
|
human
|
HeLa-contaminant
|
originally established from oral epidermoid carcinoma, HeLa-contaminated
|
KCL-22
|
JCRB1317
|
human
|
hemo-lymphocytic
|
leukemia, chronic myelocytic, Ph1-positive
|
KD
|
JCRB9103
|
human
|
oral
|
fibroblast, lip
|
KG-1
|
JCRB0065
|
human
|
hemo-lymphocytic
|
leukemia, acute myeloblastic
|
KG-1
|
JCRB9051
|
human
|
hemo-lymphocytic
|
leukemia, acute myelogenous
|
KG-1-C
|
JCRB0236
|
human
|
neural
|
mixed glioma, GFAP-negative, S-100-positive
|
KHM-10B
|
JCRB0165
|
human
|
hemo-lymphocytic
|
lymphoma, Burkitt's, ALL-L3 cell line with a 13q34 abnormality, constitutive c-myc, max expression
|
KHM-1B
|
JCRB0133
|
human
|
hemo-lymphocytic
|
myeloma, multiple, with hyperamylasemia.
|
KHM-3S
|
JCRB0138
|
human
|
lung (cancer)
|
small cell carcinoma, HTLV-1gene integration
|
KHM-5M
|
JCRB0148
|
human
|
thyroid
|
thyroid carcinoma, undifferentiated, IL-8 producing
|
KHYG-1
|
JCRB0156
|
human
|
hemo-lymphocytic
|
leukemia, NK cell-like, IL-2 dependent
|
Ki-JK
|
JCRB1065
|
human
|
hemo-lymphocytic
|
lymphoma, anaplastic giant cell, Ki-1(CD30)-positive
|
KINGS-1
|
IFO50435
|
human
|
neural
|
astrocytoma, anaplastic, GFAP, S-100, vimentin, CD13 and HNK-1-positive
|
KMBC-2
|
JCRB1148
|
human
|
bladder
|
urinary bladder carcinoma
|
KMH-2
|
JCRB1066
|
human
|
thyroid
|
thyroid anaplastic carcinoma
|
KML-1
|
JCRB1347
|
human
|
hemo-lymphocytic
|
lymphoma, non-Hodgkins
|
KMLS-1
|
JCRB0200
|
human
|
sarcoma
|
liposarcoma
|
KMM-1
|
JCRB1180
|
human
|
hemo-lymphocytic
|
myeloma
|
KMPC-3
|
JCRB1150
|
human
|
kidney
|
cell line derived from renal pelvis
|
KMRC-1
|
JCRB1010
|
human
|
kidney
|
renal clear cell carcinoma
|
KMRC-2
|
JCRB1011
|
human
|
kidney
|
renal clear cell carcinoma
|
KMRC-20
|
JCRB1071
|
human
|
kidney
|
renal cancer
|
KMRC-3
|
JCRB1012
|
human
|
kidney
|
renal clear cell carcinoma (growth is very slow)
|
KMRC-5
|
JCRB1007
|
human
|
kidney
|
renal clear cell carcinoma
|
KMRM-M1
|
JCRB1014
|
human
|
kidney
|
renal carcinoma
|
KMS-11
|
JCRB1179
|
human
|
hemo-lymphocytic
|
myeloma, multiple, IgG kappa-secreting, EBNA(-)
|
KMS-12-BM
|
JCRB0429
|
human
|
hemo-lymphocytic
|
myeloma, late stage of B-cell differentiation
|
KMS-12-PE
|
JCRB0430
|
human
|
hemo-lymphocytic
|
myeloma, late stage of B-cell differentiation
|
KMS-20
|
JCRB1196
|
human
|
hemo-lymphocytic
|
myeloma
|
KMS-21BM
|
JCRB1185
|
human
|
hemo-lymphocytic
|
myeloma
|
KMS-26
|
JCRB1187
|
human
|
hemo-lymphocytic
|
myeloma
|
KMS-27
|
JCRB1188
|
human
|
hemo-lymphocytic
|
myeloma
|
KMS-28BM
|
JCRB1192
|
human
|
hemo-lymphocytic
|
myeloma
|
KMS-28PE
|
JCRB1191
|
human
|
hemo-lymphocytic
|
myeloma
|
KMS-34
|
JCRB1195
|
human
|
hemo-lymphocytic
|
myeloma
|
KMS-6
|
JCRB0432
|
human
|
embryo
|
fibroblast, normal diploid
|
KMST-6
|
JCRB0433
|
human
|
embryo
|
fibroblast, immortalized by 60Co irradiation, derivative of KMS-6
|
KMST-6/T
|
JCRB0434
|
human
|
embryo
|
fibroblast, immortalized after extensive passages, derivative of KMS-6
|
KNS-42
|
IFO50356
|
human
|
neural
|
glioma, GFAP-positive, S-100 and NSE-negative
|
KNS-60
|
IFO50357
|
human
|
neural
|
glioma, GFAP, S-100 and NSE-negative
|
KNS-62
|
IFO50358
|
human
|
lung (cancer)
|
bronchial squamous carcinoma, metastasis to brain
|
KNS-81
|
IFO50359
|
human
|
neural
|
glioma, GFAP and S-100-positive, NSE-negative
|
KNS-81-FD
|
IFO50444
|
human
|
neural
|
glioma, derivative of KNS-81 adapted to serum-free medium
|
KNS-89
|
IFO50360
|
human
|
neural
|
gliosarcoma, GFAP and NSE-positive, S-100-negative (contamination by U-251 MG has been suspected, excluded from catalogue.)
|
KO51
|
JCRB0122
|
human
|
hemo-lymphocytic
|
leukemia, acute myeloblastic, contamination of K562 has been suspected.
|
KO52
|
JCRB0123
|
human
|
hemo-lymphocytic
|
leukemia, acute myeloblastic
|
KON
|
JCRB0194
|
human
|
oral
|
squamous carcinoma, mouth, ras P21 expression
|
KOSC-2 cl3-43
|
JCRB0126.1
|
human
|
oral
|
squamous carcinoma, stage III, oral floor
|
KOSC-3
|
JCRB0127
|
human
|
oral
|
squamous carcinoma, stage III, lower gingiva, contamination by Ca9-22 was suspected.
|
KP-1N
|
JCRB0177.0
|
human
|
pancreas
|
pancreatic cancer, adenocarcinoma (distribution is suspended)
|
KP-1NL
|
JCRB0177.1
|
human
|
pancreas
|
pancreatic cancer, adenocarcinoma, highly metastatic to liver in nude mice (distribution is suspended)
|
KP-2
|
JCRB0181
|
human
|
pancreas
|
pancreatic ductal cell carcinoma, moderately differentiated tubular adenocarcinoma
|
KP-3
|
JCRB0178.0
|
human
|
pancreas
|
pancreatic cancer, adenosquamous carcinoma
|
KP-3L
|
JCRB0178.1
|
human
|
pancreas
|
pancreatic cancer, adenosquamous carcinoma, highly metastatic to liver in nude mice
|
KP-4
|
JCRB0182
|
human
|
pancreas
|
pacnreatic ductal cell carcinoma, secreting PTHrP
|
KP-N-RT-BM-1
|
IFO50432
|
human
|
neural
|
neuroblastoma, from bone marrow, neuronal and Schwannian differentiation
|
KP-N-SI9s
|
IFO50433
|
human
|
neural
|
neuroblastoma, from lymph node, smooth muscle marker-expressing
|
KP-N-YN
|
IFO50431
|
human
|
neural
|
neuroblastoma, from lymph node, smooth muscle marker-expressing
|
KS-1
|
IFO50436
|
human
|
neural
|
glioblastoma
|
KT-5
|
IFO50161
|
mouse
|
neural
|
astrocyte line, GFAP-positive, (C3H/He mouse)
|
KU812
|
IFO50363
|
human
|
hemo-lymphocytic
|
leukemia, chronic myeloid
|
KU812
|
JCRB0104
|
human
|
hemo-lymphocytic
|
leukemia, chronic myeloid
|
KU812E
|
JCRB0104.1
|
human
|
hemo-lymphocytic
|
leukemia, chronic myeloid
|
KU812F
|
JCRB0104.2
|
human
|
hemo-lymphocytic
|
leukemia, chronic myeloid
|
KUM10
|
JCRB1176
|
mouse
|
bone marrow
|
osteoblastic cell line, mesenchymal stem cell like, (C3H/He mouse)
|
KUM3
|
JCRB1134
|
mouse
|
bone marrow
|
osteoblastic cell line, mesenchymal stem cell like, (C3H/He mouse)
|
KUM4
|
JCRB1135
|
mouse
|
bone marrow
|
osteoblastic cell line, mesenchymal stem cell like, (C3H/He mouse)
|
KUM5
|
JCRB1178
|
mouse
|
bone marrow
|
osteoblastic cell line, mesenchymal stem cell like, (C3H/He mouse)
|
KUM6
|
JCRB1202
|
mouse
|
bone marrow
|
osteoblastic cell line, mesenchymal stem cell like, (C3H/He mouse)
|
KUM7
|
JCRB1204
|
mouse
|
bone marrow
|
osteoblastic cell line, mesenchymal stem cell like, (C3H/He mouse)
|
KUM9
|
JCRB1139
|
mouse
|
bone marrow
|
osteoblastic cell line, mesenchymal stem cell like, (C3H/He mouse)
|
KURAMOCHI
|
JCRB0098
|
human
|
ovary
|
undifferentiated carcinoma, ascites
|
KUSA-A1
|
JCRB1119
|
mouse
|
bone marrow
|
osteoblastic cell line, mesenchymal stem cell like, (C3H/He mouse)
|
KUSA-H1
|
JCRB1129
|
mouse
|
bone marrow
|
osteoblastic cell line, mesenchymal stem cell like, (C3H/He mouse)
|
KUSA-O
|
JCRB1132
|
mouse
|
bone marrow
|
osteoblastic cell line, mesenchymal stem cell like, (C3H/He mouse)
|
KY821
|
JCRB0105
|
human
|
hemo-lymphocytic
|
leukemia, acute myeloid
|
KY821A3
|
JCRB0105.1
|
human
|
hemo-lymphocytic
|
leukemia, acute myeloid, subclone of KY821
|
KYM-1
|
JCRB0627
|
human
|
sarcoma
|
rhabdomyosarcoma, neck
|
KYSE110
|
JCRB1064
|
human
|
esophagus
|
squamous carcinoma, poorly differentiated, (Japan domestic use only, company users are requested to conclude MTA with originator before order)
|
KYSE140
|
JCRB1063
|
human
|
esophagus
|
squamous carcinoma, moderately differentiated, (Japan domestic use only, company users are requested to conclude MTA with originator before order)
|
KYSE150
|
JCRB1095
|
human
|
esophagus
|
squamous carcinoma, poorly differentiated, (Japan domestic use only, company users are requested to conclude MTA with originator before order)
|
KYSE170
|
JCRB1082
|
human
|
esophagus
|
squamous carcinoma, moderately differentiated, (Japan domestic use only, company users are requested to conclude MTA with originator before order)
|
KYSE180
|
JCRB1083
|
human
|
esophagus
|
squamous carcinoma, well differentiated, (Japan domestic use only, company users are requested to conclude MTA with originator before order)
|
KYSE220
|
JCRB1086
|
human
|
esophagus
|
squamous carcinoma, moderately differentiated, (Japan domestic use only, company users are requested to conclude MTA with originator before order)
|
KYSE270
|
JCRB1087
|
human
|
esophagus
|
squamous carcinoma, well differentiated, (Japan domestic use only, company users are requested to conclude MTA with originator before order)
|
KYSE30
|
JCRB0188
|
human
|
esophagus
|
squamous carcinoma, well-differentiated, (Japan domestic use only, company users are requested to conclude MTA with originator before order)
|
KYSE50
|
JCRB0189
|
human
|
esophagus
|
squamous carcinoma, poorly differentiated, (Japan domestic use only, company users are requested to conclude MTA with originator before order)
|
KYSE70
|
JCRB0190
|
human
|
esophagus
|
squamous carcinoma, poorly differentiated, (Japan domestic use only, company users are requested to conclude MTA with originator before order)
|
L
|
Page Top
|
|
|
|
L alpha
|
JCRB0125
|
mouse
|
skin
|
L cell line introduced with poliovirus receptor protein alpha gene, thymidine kinase defective
|
L cl 1D
|
JCRB0722
|
mouse
|
skin
|
fibroblast, thymidine kinase-deficient, (C3H mouse)
|
L.P3
|
JCRB0648
|
mouse
|
skin
|
serum-free adapted L929 cell line
|
L.P3(S)
|
JCRB0605
|
mouse
|
skin
|
L cell derived, can grow in a serum-free medium, (C3H mouse)
|
L1210
|
JCRB9026
|
mouse
|
hemo-lymphocytic
|
leukemia, lymphocytic, (DBA/2 mouse)
|
L-2
|
JCRB9053
|
rat
|
lung
|
***** lung
|
L2C
|
IFO50210
|
guinea pig
|
hemo-lymphocytic
|
leukemic cell, maintainable only by transplantation
|
L5178Y
|
JCRB0709
|
mouse
|
hemo-lymphocytic
|
lymphoma, methylcholanthrene induced, (DBA/2 mouse)
|
L5178Y TK+/-3.7.2c
|
JCRB0709.1
|
mouse
|
hemo-lymphocytic
|
L5178Y derivative, thymidine kinase +/- heterozygotic line
|
L5178Y ts2
|
JCRB0723
|
mouse
|
hemo-lymphocytic
|
L5178Y derivative, abnormal cell division at non-permissive temperature
|
L5178Y ts39
|
JCRB0724
|
mouse
|
hemo-lymphocytic
|
L5178Y derivative, micronucleation at non-permissive temperature
|
L6
|
IFO50364
|
rat
|
muscular system
|
skeletal muscle myoblast
|
L6
|
JCRB9081
|
rat
|
muscular system
|
skeletal muscle myoblast
|
L6TG
|
JCRB0209
|
rat
|
muscular system
|
skeletal muscle myoblast, 6-thioguanine-resistant
|
L6TG Cap
|
JCRB0210
|
rat
|
muscular system
|
skeletal muscle myoblast, 6-thioguanine, chloramphencol-resistant
|
LC-1 sq
|
JCRB0258
|
human
|
lung (cancer)
|
squamous cell carcinoma
|
LC4-1
|
JCRB0114
|
human
|
hemo-lymphocytic
|
leukemia, acute non T lymphoblastic
|
LC540
|
JCRB9064
|
rat
|
testis
|
Leydig cell testicular tumor
|
LI90
|
JCRB0160
|
human
|
liver, gallbladder
|
liver Ito cells (limited life span)
|
LK-2
|
JCRB0829
|
human
|
lung (cancer)
|
squamous cell carcinoma
|
LLC-PK1
|
JCRB0060
|
pig
|
kidney
|
susceptible to rubella, vaccinia and herpes viruses
|
LLC-RK1
|
JCRB9034
|
rabbit
|
kidney
|
an aneuploid cell line, (New Zealand white rabbit)
|
LMH
|
JCRB0237
|
chicken
|
liver
|
hepatocelluler carcinoma, diethylnitrosamine induced
|
LoVo
|
IFO50067
|
human
|
colon
|
adenocarcinoma, carcinoembryonic antigen-producing
|
LoVo
|
JCRB9083
|
human
|
colon
|
adenocarcinoma, carcinoembryonic antigen-producing
|
Lu-134-A-H
|
JCRB0235
|
human
|
lung (cancer)
|
small cell carcinoma, classic type
|
Lu-134-B
|
JCRB0169
|
human
|
lung (cancer)
|
small cell carcinoma
|
Lu-135
|
JCRB0170
|
human
|
lung (cancer)
|
small cell carcinoma, variant type
|
LU65
|
JCRB0079
|
human
|
lung (cancer)
|
giant cell carcinoma
|
LU65A
|
JCRB0054
|
human
|
lung (cancer)
|
giant cell carcinoma
|
LU65B
|
JCRB0055
|
human
|
lung (cancer)
|
giant cell carcinoma
|
LU65C
|
JCRB0056
|
human
|
lung (cancer)
|
giant cell carcinoma
|
LU99
|
JCRB0080
|
human
|
lung (cancer)
|
giant cell carcinoma
|
LU99A
|
JCRB0044
|
human
|
lung (cancer)
|
giant cell carcinoma
|
LU99B
|
JCRB0057
|
human
|
lung (cancer)
|
giant cell carcinoma
|
LU99C
|
JCRB0058
|
human
|
lung (cancer)
|
giant cell carcinoma
|
LYM-1.P3
|
JCRB0144.1
|
rat
|
lymph node
|
sticky cell from lymph node, serum-free, (JAR-2 rat)
|
LYM-1.P3B
|
JCRB0144.1B
|
rat
|
lymph node
|
sticky cell from lymph node, subclone of LYM-1.P3
|
LYM-1.P3D
|
JCRB0144.1D
|
rat
|
lymph node
|
sticky cell from lymph node, subclone of LYM-1.P3
|
M
|
Page Top
|
|
|
|
M
|
JCRB0152.1
|
rat
|
liver
|
DAB transformed liver cell line, (JAR rat)
|
M.dunni(Clone III8C)
|
JCRB9124
|
pygmy mouse
|
tail
|
normal, support the growth of all 4 classes of MuLV
|
M.P3
|
JCRB0152.2
|
rat
|
liver
|
DAB transformed liver cell line, protein and lipid-free culture, (JAR rat)
|
M.P3
|
JCRB0152.3
|
rat
|
liver
|
DAB transformed liver cell line, protein and lipid-free culture, deposited directly by original developer (JAR rat)
|
M1
|
IFO50006
|
mouse
|
hemo-lymphocytic
|
spontaneous myeloid leukemia, differentiation into macrophage/granulocyte, (SL mouse)
|
M1-T22
|
JCRB0110
|
mouse
|
hemo-lymphocytic
|
leukemia, spontaneous myeloblastic, differentiation-inducible, (SL mouse)
|
m5S
|
JCRB1322
|
mouse
|
skin
|
3T3-like near-diploid, derived from embryonic skin (ICR/Jcl mouse)
|
MA-89
|
IFO50293
|
mouse
|
neural
|
normal mixed glial culture, (C3H/He mouse)
|
Marcus
|
IFO50290
|
human
|
neural
|
astrocytoma, GFAP-negative, (distribution is suspended)
|
MB86
|
JCRB0090
|
mouse
|
antibody-producing hybridoma
|
anti-Igh6-4 antibody-producing, IgM, (BALB/c mouse)
|
MBT2
|
IFO50041
|
mouse
|
bladder
|
bladder carcinoma
|
MCAS
|
JCRB0240
|
human
|
ovary
|
mucinous cystadenocarcinoma
|
MCA-TCL16
|
JCRB0712
|
mouse
|
embryo
|
C3H10T1/2 cl-8 derivative, methylcholanthrene-transformed, (C3H mouse)
|
MCF-7
|
JCRB0134
|
human
|
mammary
|
mammary tumor
|
MDBK (NBL-1)
|
IFO50014
|
bovine
|
kidney
|
established from normal kidney
|
MDBK (NBL-1)
|
JCRB9028
|
bovine
|
kidney
|
established from normal kidney
|
MDBK.P3
|
JCRB0716
|
bovine
|
kidney
|
normal kidney, MDBK derivative, no serum required
|
MDCK (NBL-2)
|
IFO50071
|
dog
|
kidney
|
established from normal kidney, susceptible for many viral species
|
MDCK (NBL-2)
|
JCRB9029
|
dog
|
kidney
|
established from normal kidney, susceptible for many viral species
|
MDCK.P3
|
JCRB0717
|
dog
|
kidney
|
normal kidney, MDCK derivative, no serum required
|
MDM2-RNB
|
IFO50490
|
rat
|
neural
|
human MDM2 protein-expressing astrocyte cell line, (Wistar rat)
|
ME-180
|
JCRB0810
|
human
|
uterine cervix
|
cervical carcinoama
|
MEB 5
|
JCRB0145
|
mouse
|
neural
|
CNS stem cell line, HPV type 16 E7-immortalized, (C3H/He mouse)
|
MEB5
|
IFO50472
|
mouse
|
neural
|
CNS stem cell line, HPV type 16 E7-immortalized, (C3H/He mouse)
|
MEG-01
|
IFO50151
|
human
|
hemo-lymphocytic
|
leukemia, chronic megakaryoblastic
|
MEG-01s
|
IFO50473
|
human
|
hemo-lymphocytic
|
leukemia, chronic megakaryoblastic, MEG-01-derivative
|
MEG-01SSF
|
IFO50294
|
human
|
hemo-lymphocytic
|
leukemia, chronic megakaryoblastic, MEG-01s-derivative adapted to serum-free medium
|
MEG-A2
|
IFO50478
|
human
|
hemo-lymphocytic
|
leukemia, chronic myelogenous, megakaryoblastic cell line
|
Mewo
|
JCRB0066
|
human
|
melanoma
|
malignant melanoma
|
MG5
|
IFO50520
|
mouse
|
neural
|
microglial cell line, p53-deficient. Requires A1 conditioned medium for culture.
|
MG-63
|
IFO50108
|
human
|
sarcoma
|
osteosarcoma
|
MIA PaCa-2
|
JCRB0070
|
human
|
pancreas
|
pancreatic cancer
|
MiTen
|
JCRB0072
|
human
|
skin
|
Lesh-Nyhan syndrome, skin fibroblast
|
Miz-1
|
IFO50300
|
human
|
embryo
|
limb interstitial tissue, normal diploid fibroblast
|
MK.P3
|
JCRB0607.1
|
monkey, Cynomolgus
|
kidney
|
MK (JTC-12) cells adapted to serum-free medium
|
MK.P3(F)
|
JCRB0607
|
monkey, Cynomolgus
|
kidney
|
other name is JTC-12.P3(F)
|
MKN1
|
JCRB0252
|
human
|
stomach
|
adenosquamous carcinoma
|
MKN28
|
JCRB0253
|
human
|
stomach
|
tubular adenocarcinoma, moderately differentiated, contamination with MKN74 has been suspected
|
MKN45
|
JCRB0254
|
human
|
stomach
|
adenocarcinoma, poorly differentiated
|
MKN7
|
JCRB1025
|
human
|
stomach
|
tubular adenocarcinoma, well differentiated
|
MKN74
|
JCRB0255
|
human
|
stomach
|
tubular adenocarcinoma, moderately differentiated
|
MKPL-1
|
JCRB1325
|
human
|
hemo-lymphocytic
|
leukemia, acute megakaryoblastic
|
MLMA
|
JCRB0146
|
human
|
hemo-lymphocytic
|
lymphoma, malignant, hairy B-cell line
|
Mm1
|
IFO50008
|
mouse
|
hemo-lymphocytic
|
spontaneous myeloid leukemia, M-1-derivative, macrophage-like phenotype, (SL mouse)
|
Mm2T
|
JCRB0609
|
Indian Muntjak
|
thymus
|
thymus
|
Mm2T.P3
|
JCRB0609.1
|
Indian Muntjak
|
thymus
|
thymus, serum-free adapted Mm2T
|
Mm2T12.P3
|
JCRB0650.1
|
Indian Muntjak
|
thymus
|
subline of Mm2T, serum-free
|
MMT 060562
|
JCRB9077
|
mouse
|
mammary
|
spontaneous mammary tumor
|
MOLT-3
|
JCRB9048
|
human
|
hemo-lymphocytic
|
leukemia, acute lymphoblastic
|
MOLT-4
|
IFO50362
|
human
|
hemo-lymphocytic
|
leukemia, acute T lymphoblastic
|
MOLT-4
|
JCRB9031
|
human
|
hemo-lymphocytic
|
leukemia, acute T lymphoblastic
|
MOLT-4F
|
JCRB0021
|
human
|
hemo-lymphocytic
|
leukemia, acute T lymphoblastic
|
MOR35.4.12
|
JCRB1342.02
|
mouse
|
antibody-producing hybridoma
|
anti-morphine antibody, IgG1(k)
|
MOR8.2.1
|
JCRB1342.01
|
mouse
|
antibody-producing hybridoma
|
anti-morphine antibody, IgG1(k)
|
MOR83.3.10
|
JCRB1342.05
|
mouse
|
antibody-producing hybridoma
|
anti-morphine antibody, IgG1(k)
|
MPC 11 OUAr
|
JCRB9106
|
mouse
|
hemo-lymphocytic
|
myeloma, ourbain resistant
|
MRC-5
|
IFO50073
|
human
|
lung
|
fetal lung, normal diploid fibroblast
|
MRC-5
|
JCRB9008
|
human
|
lung
|
fetal lung, normal diploid fibroblast
|
MRC-5-30
|
JCRB0521
|
human
|
lung
|
fetal lung, normal diploid fibroblast, PDL=about 30
|
MRC-5-40
|
JCRB0522
|
human
|
lung
|
fetal lung, normal diploid fibroblast, PDL=about 40
|
MRC-5-50
|
JCRB0523
|
human
|
lung
|
fetal lung, normal diploid fibroblast, PDL=about 50
|
MRC-9
|
IFO50072
|
human
|
lung
|
fetal lung, normal diploid fibroblast
|
MRC-9
|
JCRB9060
|
human
|
lung
|
fetal lung, normal diploid fibroblast
|
MRC-9-30
|
JCRB0524
|
human
|
lung
|
fetal lung, normal diploid fibroblast, PDL=about 30, (not available.)
|
MRK-nu-1
|
JCRB0628
|
human
|
mammary
|
mammary carcinoma
|
MS-1-L
|
JCRB1081
|
human
|
lung (cancer)
|
small cell carcinoma, PTHrP producing
|
MS-653-A
|
JCRB1001.1
|
rat
|
sarcoma
|
fibrosarcoma, methylcholantheren-induced, highly tumorigenic, (Donryu rat)
|
MS-653-G
|
JCRB1001.2
|
rat
|
sarcoma
|
fibrosarcoma, methylcholantheren-induced, less tumorigenic, (Donryu rat)
|
MSK
|
JCRB0259
|
rat
|
sarcoma
|
osteosarcoma, 32P-induced, (F344 rat)
|
MSS31
|
IFO50375
|
mouse
|
spleen
|
spleen stromal cell line, (C57BL/6 mouse)
|
MSS62
|
IFO50376
|
mouse
|
spleen
|
spleen stromal cell line, (C57BL/6 mouse)
|
MT-1
|
JCRB1209
|
human
|
hemo-lymphocytic
|
Leukemia, ***** T cell, HTLV-I-positive. (This cell line is supplied from National Institute of Biomedical Innovation.)
|
MT-2
|
JCRB1210
|
human
|
hemo-lymphocytic
|
HTLV-I-transformed leukocytes, HTLV-I-positive. (This cell line is supplied from National Institute of Biomedical Innovation.)
|
MT-3
|
JCRB1217
|
human
|
hemo-lymphocytic
|
HTLV-I-transformed leukocytes, HTLV-I-positive. (This cell line is supplied from National Institute of Biomedical Innovation.)
|
MT-4
|
JCRB0135
|
human
|
hemo-lymphocytic
|
HTLV-I-transformed leukocytes, HTLV-I antigen-positive. (This cell line is supplied from National Institute of Biomedical Innovation.)
|
MT-4
|
JCRB1216
|
human
|
hemo-lymphocytic
|
HTLV-I-transformed leukocytes, HTLV-I-positive. (This cell line is supplied from National Institute of Biomedical Innovation.)
|
MT-45-5-3
|
JCRB1304
|
mouse
|
antibody-producing hybridoma
|
anti-metallothionein antibody-producing, IgG1(k)
|
MTA
|
IFO50513
|
human
|
hemo-lymphocytic
|
leukemia, NK-like T cell line
|
Mv 1 Lu
|
JCRB9128
|
mink
|
lung
|
useful for focus forming assays of murine and feline sarcoma virus
|
MY
|
JCRB0158.0
|
human
|
hemo-lymphocytic
|
leukemia, acute biphenotypic, bone marrow mononuclear cell line with variant BCR/ABL breakpoint expressing P180BCR/ABL
|
MY-M12
|
JCRB0158.1
|
human
|
hemo-lymphocytic
|
leukemia, acute biphenotypic, subclone of the MY cells
|
MY-M13
|
JCRB0158.2
|
human
|
hemo-lymphocytic
|
leukemia, acute biphenotypic, subclone of the MY cells
|
N
|
Page Top
|
|
|
|
N18-RE-105
|
IFO50221
|
mouse x rat
|
neural
|
N18TG2 x Fischer rat embryonic neural retina
|
NAGL-1
|
IFO50479
|
human
|
hemo-lymphocytic
|
leukemia, acute pre B lymphoblastic, B cell line
|
NALL-1
|
JCRB1332
|
human
|
hemo-lymphocytic
|
leukemia, acute lymphocytic
|
Namalwa
|
IFO50040
|
human
|
hemo-lymphocytic
|
lymphoma, Burkitt's
|
NB(TU)1-10
|
JCRB0154
|
human
|
neural
|
neuroblastoma, stage III
|
NB-1
|
IFO50295
|
human
|
neural
|
neuroblastoma
|
NB-1
|
JCRB0621
|
human
|
neural
|
neuroblastoma
|
NC02
|
IFO50525
|
human
|
hemo-lymphocytic
|
leukemia, chronic myelogenous, Ph1 chromosome-positive
|
NC-37
|
IFO50039
|
human
|
hemo-lymphocytic
|
lymphoblast, Contamination of Raji cells has been suspected.
|
NCC16-P11
|
JCRB0174.0
|
human
|
uterine cervix
|
normal epithelial cells immortalized with HPV16, EGF-independent
|
NCC-IT-A3
|
JCRB1005
|
human
|
teratocarcinoma
|
teratocarcinoma from anterior mediastinum, HST-1 oncogene-expressing
|
NCC-OvC-K119
|
JCRB1308
|
human
|
ovary
|
ovarian carcinoma (growth is extremely slow)
|
NCC-RbC-39
|
JCRB1305
|
human
|
neural
|
retinoblastoma, unilateral (growth is very slow)
|
NCC-RbC-51
|
JCRB1182
|
human
|
neural
|
retinoblastoma, bilateral
|
NCC-RbC-54
|
JCRB1183
|
human
|
neural
|
retinoblastoma, bilateral
|
NCC-RbC-56
|
JCRB1212
|
human
|
neural
|
retinoblastoma, bilateral
|
NCC-RbC-57
|
JCRB1190
|
human
|
neural
|
retinoblastoma, unilateral (growth is very slow)
|
NCC-RbC-67
|
JCRB1214
|
human
|
neural
|
retinoblastoma, unilateral
|
NCC-RbC-92
|
JCRB1221
|
human
|
neural
|
retinoblastoma, unilateral (growth is very slow)
|
NCC-RbC-T1
|
JCRB1223
|
human
|
neural
|
retinoblastoma, bilateral (growth is very slow)
|
NCC-StC-K140
|
JCRB1228
|
human
|
stomach
|
adenocarcinoma
|
NCE 16IIA
|
JCRB1090
|
human
|
uterine cervix
|
normal keratinocyte immortalized with HPV16
|
NCE16
|
JCRB0140
|
human
|
uterine cervix
|
normal keratinocyte immortalized with HPV16
|
NCR-G1
|
JCRB1166
|
human
|
testis
|
testicular germ cell tumor, yolk sac tumor-like characteristics
|
NCR-G2
|
JCRB1167
|
human
|
testis
|
testicular germ cell tumor, embrional carcinoma
|
NCR-G3
|
JCRB1168
|
human
|
testis
|
testicular germ cell tumor, embryonal carcinoma
|
NCR-G4
|
JCRB1175
|
human
|
testis
|
testicular germ cell tumor, embrional carcinoma
|
NCTC clone 1469
|
IFO50080
|
mouse
|
liver
|
normal liver-derived, (C3H/An mouse)
|
NCTC Clone 1469
|
JCRB9075
|
mouse
|
liver
|
normal liver-derived, (C3H/An mouse)
|
NCTC clone 929
|
IFO50409
|
mouse
|
skin
|
fibroblast, subclone of strain L, (C3H/An mouse)
|
NCTC Clone 929
|
JCRB9003
|
mouse
|
skin
|
fibroblast, subclone of strain L, (C3H/An mouse)
|
NEC14
|
JCRB0162
|
human
|
testis
|
testicular germ cell tumor
|
NEC8
|
JCRB0250
|
human
|
testis
|
testicular germ cell tumor
|
Neuro-2a
|
IFO50081
|
mouse
|
neural
|
neuroblastoma, (A albino mouse)
|
Neuro-2aTG
|
IFO50495
|
mouse
|
neural
|
neuroblastoma, 6-thioguanine-resistant,HAT-sensitive, (A albino mouse)
|
NG-3Y1-T15L
|
JCRB0739
|
rat
|
embryo
|
3Y1 derivative, transformed by MNNG, (Fischer rat)
|
NG-3Y1-T308
|
JCRB0740
|
rat
|
embryo
|
3Y1 derivative, transformed by MNNG, (Fischer rat)
|
NG-3Y1-T6R
|
JCRB0741
|
rat
|
embryo
|
3Y1 derivative, transformed by MNNG, (Fischer rat)
|
NH-12
|
JCRB0833
|
human
|
neural
|
neuroblastoma, adrenal gland
|
NH-6
|
JCRB0832
|
human
|
neural
|
neuroblastoma, adrenal gland, opsomyoclonus, truncal ataxia
|
NIH 3T3 p-7 cl-3
|
IFO50019
|
mouse
|
embryo
|
fibroblast, contact inhibited, (NIH Swiss mouse)
|
NIH/3T3 clone 5611
|
JCRB0615
|
mouse
|
embryo
|
fibroblast, contact inhibited, (NIH Swiss mouse)
|
NIL
|
IFO50018
|
hamster, Syrian
|
embryo
|
transformed from hamster fibroblast
|
NIL-SF2
|
IFO50426
|
hamster, Syrian
|
embryo
|
NIL subline adapted to serum-free medium
|
NJG
|
IFO50322
|
human
|
uterus
|
gestational uterine choriocarcinoma
|
NKM-1
|
IFO50476
|
human
|
hemo-lymphocytic
|
leukemia, acute myeloid, myeloid leukemia cells, responsive to G-CSF and M-CSF for growth
|
NKY113
|
IFO50279
|
mouse
|
antibody-producing hybridoma
|
MSW113 antibody, recognizing a cancer-associated olygosaccharide
|
NM-1
|
JCRB0155
|
bovine
|
vascular system
|
aortic normal endothelial cell, (SMA-positive smooth muscle cells are intermingled.)
|
NMC-G1
|
IFO50467
|
human
|
neural
|
glioma, FGF-9-producing
|
no.10
|
IFO50368
|
human
|
neural
|
glioma, anaplastic, GFAP-positive
|
no.11
|
IFO50369
|
human
|
neural
|
glioma, anaplastic, GFAP-positive
|
NOMO-1
|
IFO50474
|
human
|
hemo-lymphocytic
|
leukemia, acute monocytic, promonocytic leukemia cells
|
NOMO-1/ADM
|
JCRB1069
|
human
|
hemo-lymphocytic
|
leukemia, acute monocytic, adriamycin-resistant derivative of NOMO-1
|
NOMO-1s
|
IFO50475
|
human
|
hemo-lymphocytic
|
leukemia, acute monocytic, NOMO-1-derivative adapted to serum-free medium
|
NOZ
|
JCRB1033
|
human
|
liver, gallbladder
|
gallbladder carcinoma, tubular adenocarcinoma, moderately differentiated
|
NRG
|
JCRB1138
|
mouse
|
bone marrow
|
osteoblastic cell line, mesenchymal stem cell like, (C3H/He mouse)
|
NRK-49F
|
IFO50481
|
rat
|
kidney
|
fibroblastic clone of NRK (normal rat kidney) cells, useful for transformation assays, (Osbone-Mendel rat)
|
NRK-49F
|
JCRB9067
|
rat
|
kidney
|
fibroblastic clone of NRK (normal rat kidney) cells, useful for transformation assays, (Osbone-Mendel rat)
|
NRK-52E
|
IFO50480
|
rat
|
kidney
|
epithelioid clone of NRK (normal rat kidney) cells, (Osbone-Mendel rat)
|
NTI-4
|
JCRB0220
|
human
|
embryo
|
fibroblast, fetus, half body, bottom
|
NTI-5
|
JCRB0222
|
human
|
embryo
|
fibroblast, fetus, half a body
|
NUGC-2
|
JCRB0821
|
human
|
stomach
|
adenocarcinoma, poorly differentiated
|
NUGC-3
|
JCRB0822
|
human
|
stomach
|
adenocarcinoma, poorly differentiated
|
NUGC-4
|
JCRB0834
|
human
|
stomach
|
adenocarcinoma, poorly differentiated, signet ring cell carcinoma
|
NY
|
JCRB0614
|
human
|
sarcoma
|
osteosarcoma, femur
|
O
|
Page Top
|
|
|
|
OCUG-1
|
JCRB0191
|
human
|
liver, gallbladder
|
gallbladder carcinoma, malignant
|
OCUM-1
|
JCRB0192
|
human
|
stomach
|
adenocarcinoma, poorly differentiated, containing signet ring cells
|
OHP101.B11.1
|
JCRB1316.2
|
mouse
|
antibody-producing hybridoma
|
anti-17alpha-hydroxyprogesterone, IgG(k)
|
OHP138.H8.1
|
JCRB1316.3
|
mouse
|
antibody-producing hybridoma
|
anti-17alpha-hydroxyprogesterone, IgG(k)
|
OHP1E9.3.1
|
JCRB1316.4
|
mouse
|
antibody-producing hybridoma
|
anti-17alpha-hydroxyprogesterone, IgG(k)
|
OHP57.G6.1
|
JCRB1316.1
|
mouse
|
antibody-producing hybridoma
|
anti-17alpha-hydroxyprogesterone, IgG(k)
|
OHP7D7.2.3
|
JCRB1316.6
|
mouse
|
antibody-producing hybridoma
|
anti-17alpha-hydroxyprogesterone, IgG(k)
|
OKa-C-1
|
JCRB1343
|
human
|
lung (cancer)
|
squamous cell carcinoma, poorly differentiated, G-CSF and PTHrP producing
|
ONS-76
|
IFO50355
|
human
|
neural
|
medulloblastoma
|
OSC-19
|
JCRB0198
|
human
|
oral
|
squamous carcinoma, tongue, serum-free culture
|
OSC-20
|
JCRB0197
|
human
|
oral
|
squamous carcinoma, tongue, serum-free culture
|
OTT6050
|
JCRB0720
|
mouse
|
teratoma
|
teratocarcinoma, (129/Sv mouse)
|
OUMS-23
|
JCRB1022
|
human
|
colon
|
adenocarcinoma, from familial adenomatous polyposis patient, reduction of APC gene expression
|
OUMS-24/P6X
|
JCRB1051
|
human
|
embryo
|
fibroblast, immortalized by mutant p53 and X-ray, derivative of OUMS-24
|
OUMS-27
|
IFO50488
|
human
|
sarcoma
|
chondrosarcoma, type 1 ,2 and 3 collagens; type 9 and 11 collagen mRNA; proteoglycan-producing
|
OUMS-36
|
JCRB1006.0
|
human
|
embryo
|
normal embryonic fibroblast
|
OUMS-36T-1
|
JCRB1006.1
|
human
|
embryo
|
fibroblast, immortalized by hTRT, derivative of OUMS-36
|
OUMS-36T-1F
|
JCRB1006.1F
|
human
|
embryo
|
fibroblast, immortalized by hTRT, derivative of OUMS-36
|
OUMS-36T-2
|
JCRB1006.2
|
human
|
embryo
|
fibroblast, immortalized by hTRT, derivative of OUMS-36
|
OUMS-36T-2F
|
JCRB1006.2F
|
human
|
embryo
|
fibroblast, immortalized by hTRT, derivative of OUMS-36
|
OUMS-36T-3
|
JCRB1006.3
|
human
|
embryo
|
fibroblast, immortalized by hTRT, derivative of OUMS-36
|
OUMS-36T-3F
|
JCRB1006.3F
|
human
|
embryo
|
fibroblast, immortalized by hTRT, derivative of OUMS-36
|
OUMS-36T-4
|
JCRB1006.4
|
human
|
embryo
|
fibroblast, immortalized by hTRT, derivative of OUMS-36
|
OUMS-36T-4F
|
JCRB1006.4F
|
human
|
embryo
|
fibroblast, immortalized by hTRT, derivative of OUMS-36
|
OUMS-36T-5
|
JCRB1006.5
|
human
|
embryo
|
fibroblast, immortalized by hTRT, derivative of OUMS-36
|
OUMS-36T-5F
|
JCRB1006.5F
|
human
|
embryo
|
fibroblast, immortalized by hTRT, derivative of OUMS-36
|
OUMS-36T-6
|
JCRB1006.6
|
human
|
embryo
|
fibroblast, immortalized by hTRT, derivative of OUMS-36
|
OUMS-36T-6F
|
JCRB1006.6F
|
human
|
embryo
|
fibroblast, immortalized by hTRT, derivative of OUMS-36
|
OUMS-36T-7
|
JCRB1006.7
|
human
|
embryo
|
fibroblast, immortalized by hTRT, derivative of OUMS-36
|
OUMS-36T-7F
|
JCRB1006.7F
|
human
|
embryo
|
fibroblast, immortalized by hTRT, derivative of OUMS-36
|
OUMS-36T-8
|
JCRB1006.8
|
human
|
embryo
|
fibroblast, immortalized by hTRT, derivative of OUMS-36
|
OUMS-36T-8F
|
JCRB1006.8F
|
human
|
embryo
|
fibroblast, immortalized by hTRT, derivative of OUMS-36
|
OUS-11
|
JCRB1034
|
human
|
lung
|
normal lung cells, fibroblastic
|
OV3121
|
JCRB1026
|
mouse
|
ovary
|
ovarian granulosa cell tumor, non-metastatic
|
OV3121-ras4
|
JCRB0186
|
mouse
|
ovary
|
v-Ha-ras transfected ovarian granulosa cell tumor line OV3121, highly metastatic, ((C57BL/6N x C3H/He) F1 mouse)
|
OV3121-ras7
|
JCRB0187
|
mouse
|
ovary
|
v-Ha-ras transfected ovarian granulosa cell tumor line OV3121, moderately metastatic, ((C57BL/6N x C3H/He) F1 mouse)
|
OVISE
|
JCRB1043
|
human
|
ovary
|
clear cell adenocarcinoma
|
OVKATE
|
JCRB1044
|
human
|
ovary
|
serous papillary adenocarcinoma (growth is very slow)
|
OVMANA
|
JCRB1045
|
human
|
ovary
|
clear cell adenocarcinoma, (very labile for freezing, and the viability after thawing is very low)
|
OVMIU
|
JCRB1049
|
human
|
ovary
|
adenocarcinoma, exhibits different DNA profile from OVMIU-II (possible misidentification)
|
OVMIU-II
|
JCRB1050
|
human
|
ovary
|
adenocarcinoma, exhibits different DNA profile from OVMIU (possible misidentification)
|
OVSAHO
|
JCRB1046
|
human
|
ovary
|
serous papillary adenocarcinoma
|
OVSAYO
|
JCRB1047
|
human
|
ovary
|
adenocarcinoma, exhibits the same DNA profile as OVMIU (possible misidentification)
|
OVTOKO
|
JCRB1048
|
human
|
ovary
|
clear cell adenocarcinoma
|
OZ
|
JCRB1032
|
human
|
liver, gallbladder
|
bile duct carcinoma
|
P
|
Page Top
|
|
|
|
P3.6.2.8.1
|
JCRB9109
|
mouse
|
hemo-lymphocytic
|
myeloma, IgG1 secreting, (BALB/c mouse)
|
P3/NS1/1-Ag4-1
|
JCRB0009
|
mouse
|
hemo-lymphocytic
|
myeloma, 8-azaguanine-resistant, (BALB/c mouse)
|
P3/NS1/1-Ag4-1(NS-1)
|
JCRB9107
|
mouse
|
hemo-lymphocytic
|
myeloma, plasmacytoma, non-secreting, 8-azaguanine resistant
|
P30/OHK
|
JCRB0094
|
human
|
hemo-lymphocytic
|
leukemia, acute non T non B lymphoblastic
|
P31/FUJ
|
JCRB0091
|
human
|
hemo-lymphocytic
|
leukemia, acute monocytic
|
P32/ISH
|
JCRB0095
|
human
|
hemo-lymphocytic
|
lymphoma, Burkitt's
|
P388
|
JCRB0017
|
mouse
|
hemo-lymphocytic
|
lymphoid neoplasm, methylcholanthrene-induced, (DBA/2 mouse)
|
P388D1
|
IFO50036
|
mouse
|
hemo-lymphocytic
|
lymphoid neoplasm, derived from P388, (DBA/2 mouse)
|
P388-D1
|
JCRB0016
|
mouse
|
hemo-lymphocytic
|
lymphoid neoplasm, derived from P388, (DBA/2 mouse)
|
P39/TSU
|
JCRB0092
|
human
|
hemo-lymphocytic
|
leukemia, acute myeloblastic, contamination with HL60 has been suspected.
|
P3U1
|
JCRB0708
|
mouse
|
hemo-lymphocytic
|
myeloma
|
P3X63Ag8
|
JCRB9105
|
mouse
|
hemo-lymphocytic
|
myeloma, plasmacytoma, IgG1(gamma,kappa) secreting, (BALB/c mouse)
|
P3X63-Ag8.653
|
JCRB9030
|
mouse
|
hemo-lymphocytic
|
myeloma, non-secreting, 8-azaguanine resistant, (BALB/c mouse)
|
P3X63Ag8U.1
|
JCRB9085
|
mouse
|
hemo-lymphocytic
|
myeloma, plasmacytoma, 8-azaguanine resistant, (BALB/c mouse)
|
p53-def-MOSE
|
JCRB0151.1
|
mouse
|
ovary
|
ovarian surface epithelial cell line from p53(-/-) mouse
|
P53LMACO1
|
JCRB0150
|
mouse
|
vascular system
|
aortic smooth muscle cell line from p53 knockout mouse
|
P-815
|
JCRB0078
|
mouse
|
hemo-lymphocytic
|
mastocytoma, (DBA/2 mouse)
|
PA-1
|
JCRB9061
|
human
|
teratocarcinoma
|
ovarian teratocarcinoma, from ascitic fluid
|
PA-1/6TG-r
|
JCRB1052
|
human
|
teratocarcinoma
|
ovarian teratocarcinoma, HPRT(-) subline of PA-1
|
PAI
|
JCRB0113
|
mouse
|
hemo-lymphocytic
|
myeloma, (BALB/c mouse)
|
PALL-2
|
JCRB1345
|
human
|
hemo-lymphocytic
|
leukemia, acute lymphoblastic, Ph1 chromosome-positive
|
PB-3c
|
IFO50267
|
mouse
|
hemo-lymphocytic
|
mast cell line
|
PC-12
|
IFO50278
|
rat
|
neural
|
pheochromocytoma, neuronal differentiation by NGF, grow in suspension
|
PC-12
|
JCRB0733
|
rat
|
neural
|
pheochromocytoma, , neuronal differentiation by NGF, adhesive variant
|
PC-12.P3
|
JCRB0130
|
rat
|
neural
|
PC-12 derivative adapted to serum-free culture
|
PC-12.P3
|
JCRB0130.1
|
rat
|
neural
|
PC-12 derivative adapted to serum-free culture, direct deposition by original developer
|
PC12HS
|
JCRB0266
|
rat
|
neural
|
pheochromocytoma, highly NGF-sensitive clone of PC-12
|
PC12HS.P3
|
JCRB0263.1
|
rat
|
neural
|
pheochromocytoma, serum-free adapted PC12 HS
|
PC12IS
|
JCRB0268
|
rat
|
neural
|
pheochromocytoma, NGF-insensitive clone of PC-12
|
PC12MS
|
JCRB0267
|
rat
|
neural
|
pheochromocytoma, moderately NGF-sensitive clone of PC-12
|
PC-12TG
|
IFO50496
|
rat
|
neural
|
pheochromocytoma, neuronal differentiation by NGF, 6-thioguanine-resistant,HAT-sensitive
|
PC-3
|
JCRB0077
|
human
|
lung (cancer)
|
adenocarcinoma, intermediately differentiated
|
PC-3
|
JCRB9110
|
human
|
prostate gland
|
adenocarcinoma
|
PCC4
|
JCRB0205
|
mouse
|
teratoma
|
teratocarcinoma, (129/Sv mouse)
|
PCC4 AG
|
JCRB0206
|
mouse
|
teratoma
|
teratocarcinoma, 8-azaguanine-resistant, (129/Sv mouse)
|
PCC4 AG Cap
|
JCRB0216
|
mouse
|
teratoma
|
teratocarcinoma, 8-azaguanine, chloramphenicol-resistant (129/sv mouse)
|
PCC4 Type I
|
JCRB0204
|
mouse x rat
|
cybrid
|
PCC4 fused with cytoplasts of rat myoblastic cell (L6TG Cap-r)
|
PCC4 TypeIII
|
JCRB0203
|
mouse x rat
|
cybrid
|
PCC4 fused with cytoplasts of rat myoblastic cell (L6TG Cap-r)
|
PEER
|
JCRB0830
|
human
|
hemo-lymphocytic
|
leukemia, acute T lymphocytic
|
PG-4(S+L-)
|
JCRB9125
|
cat
|
neural
|
brain derived cell line transformed with Moloney murine sarcoma virus, support type C retroviruses
|
PHK16-0b
|
JCRB0141
|
human
|
skin
|
normal keratinocyte immortalized with HPV16.
|
PJS1JTO
|
JCRB0320
|
human
|
skin
|
Peutz-Jeghers' syndrome, fibroblasts
|
PJS5JTO
|
JCRB0321
|
human
|
skin
|
Peutz-Jeghers' syndrome, fibroblasts
|
PK(15)
|
JCRB9040
|
pig
|
kidney
|
kidney
|
PKF
|
IFO50422
|
pig
|
kidney
|
susceptible to Vaccinia virus
|
PKR
|
IFO50423
|
pig
|
kidney
|
susceptible to Vaccinia virus
|
PKS
|
IFO50421
|
pig
|
kidney
|
susceptible to Vaccinia virus
|
PL-21
|
JCRB1319
|
human
|
hemo-lymphocytic
|
leukemia, acute promyelocytic
|
PL502
|
JCRB1125
|
human
|
mesenchymal stem cell
|
mesenchymal stem cells from placenta, limited life span
|
PL505
|
JCRB1128
|
human
|
mesenchymal stem cell
|
mesenchymal stem cells from placenta, limited life span
|
PL507
|
JCRB1130
|
human
|
mesenchymal stem cell
|
mesenchymal stem cells from placenta, limited life span
|
PL508
|
JCRB1194
|
human
|
mesenchymal stem cell
|
mesenchymal stem cells from placenta, limited life span
|
PL512
|
JCRB1229
|
human
|
mesenchymal stem cell
|
mesenchymal stem cells from placenta, limited life span
|
PL514
|
JCRB1300
|
human
|
mesenchymal stem cell
|
mesenchymal stem cells from placenta, limited life span
|
PL516
|
JCRB1302
|
human
|
mesenchymal stem cell
|
mesenchymal stem cells from placenta, limited life span
|
PL518
|
JCRB1307
|
human
|
mesenchymal stem cell
|
mesenchymal stem cells from placenta, limited life span
|
PL532
|
JCRB1219
|
human
|
mesenchymal stem cell
|
mesenchymal stem cells from placenta, limited life span
|
PLC/PRF/5
|
JCRB0406
|
human
|
liver, gallbladder
|
hepatoma, HBs antigen-positive
|
Pso-1
|
JCRB0641
|
human
|
*****
|
*****
|
Pso-2
|
JCRB0642
|
human
|
*****
|
*****
|
Pso-3
|
JCRB0643
|
human
|
*****
|
*****
|
Pso-4
|
JCRB0644
|
human
|
*****
|
*****
|
Pso-5
|
JCRB0645
|
human
|
*****
|
*****
|
Pso-6
|
JCRB0646
|
human
|
*****
|
*****
|
Pso-7
|
JCRB0647
|
human
|
*****
|
*****
|
PSV811
|
JCRB0604
|
human
|
skin
|
Werner's syndrome fibroblast, SV40-infected, contamination by WI-38 was suspected.
|
Pt K1
|
JCRB9039
|
marsupial (potoroo, rat kangaroo)
|
kidney
|
kidney
|
Pt K2
|
IFO50012
|
marsupial (potoroo, rat kangaroo)
|
kidney
|
kidney, epithelial-like
|
Pt K2
|
JCRB0007
|
marsupial (potoroo, rat kangaroo)
|
kidney
|
DNA replication study
|
Pt K2 (NBL-5)
|
JCRB9052
|
marsupial (potoroo, rat kangaroo)
|
kidney
|
kidney
|
Py-3Y1-S2
|
JCRB0736
|
rat
|
embryo
|
3Y1 derivative, mouse polyoma virus-transformed, (Fischer rat)
|
Q
|
Page Top
|
|
|
|
QGP-1
|
JCRB0183
|
human
|
pancreas
|
pancreatic islat cell carcinoma (somatostatinoma)
|
R
|
Page Top
|
|
|
|
R201C
|
JCRB1199
|
mouse
|
skin
|
deficient human beta-gal introduced fibroblast (background, C57BL/6 beta-galactosidase KO mouse-derived SV cells)
|
R2C
|
JCRB9055
|
rat
|
testis
|
Leydig cell testicular tumor,steroid secreting
|
Ra-1
|
JCRB1313
|
rabbit
|
hemo-lymphocytic
|
Rabbit lymphocyte cell line transformed with HTLV-I. HTLV-I-positive. (This cell line is supplied from National Institute of Biomedical Innovation.)
|
Raji
|
IFO50046
|
human
|
hemo-lymphocytic
|
lymphoma, Burkitt's
|
RAJI
|
JCRB9012
|
human
|
hemo-lymphocytic
|
lymphoma, Burkitt's
|
Ramos(RA1)
|
JCRB9119
|
human
|
hemo-lymphocytic
|
lymphoma, Burkitt's (EBV negative)
|
Ran Nor
|
JCRB9079
|
human
|
skin
|
osteoporosis, skin
|
RAT-2
|
IFO50282
|
rat
|
embryo
|
thymidine kinase deficient RAT-1 (F2408) cell line, (Fischer rat)
|
RB16KY
|
JCRB0311
|
human
|
skin
|
fibroblast from retinoblastoma(13q-) patient
|
RB24KY
|
JCRB0312
|
human
|
skin
|
fibroblast from retinoblastoma (bilateral) patient
|
RB28KY
|
JCRB0313
|
human
|
skin
|
fibroblast from retinoblastoma (unilateral) patient
|
RBL-1
|
IFO50034
|
rat
|
hemo-lymphocytic
|
leukemia, basophilic (Wister rat)
|
RBL162T
|
JCRB0328
|
human
|
hemo-lymphocytic
|
lymphoblastoid, from patient with hereditary disease with high cancer risk retinoblastoma (chromosome 13-deletion)
|
RBL182T
|
JCRB0330
|
human
|
hemo-lymphocytic
|
lymphoblastoid, from patient with hereditary disease with high cancer risk retinoblastoma (chromosome 13-deletion)
|
RBL221T
|
JCRB0329
|
human
|
hemo-lymphocytic
|
lymphoblastoid, from patient with hereditary disease with high cancer risk retinoblastoma (chromosome 13-deletion)
|
RBL-2H3
|
JCRB0023
|
rat
|
hemo-lymphocytic
|
leukemia, basophlic, mast cell line (Wistar rat)
|
RC1
|
IFO50466
|
mouse
|
antibody-producing hybridoma
|
RC1 antibody, recognizing undifferentiated neural cell-specific antigen
|
RC-1
|
JCRB0246
|
rabbit
|
cornea
|
cornea, (white rabbit)
|
RC-K8
|
JCRB1334
|
human
|
hemo-lymphocytic
|
lymphoma, malignant
|
RCM-1
|
JCRB0256
|
human
|
rectum
|
adenocarcinoma, well differentiated
|
RCN-9
|
JCRB0167
|
rat
|
colon
|
DMH induced colonic cancer, (F344/DuCrj rat)
|
RCR-1
|
JCRB0129.1
|
rat
|
neural
|
astrocyte-like cells, GFAP-positive
|
RCR-1.P3
|
JCRB0129.0
|
rat
|
neural
|
astrocyte-like cells, GFAP-positive, serum-free
|
RD
|
JCRB9072
|
human
|
sarcoma
|
rhabdomyosarcoma, embryonal
|
RERF-GC-1B
|
JCRB1009
|
human
|
stomach
|
adenocarcinoma
|
RERF-LC-Ad1
|
JCRB1020
|
human
|
lung (cancer)
|
adenocarcinoma
|
RERF-LC-Ad2
|
JCRB1021
|
human
|
lung (cancer)
|
adenocarcinoma
|
RERF-LC-FM
|
JCRB0102
|
human
|
lung (cancer)
|
small cell carcinoma, intermediate
|
RERF-LC-KJ
|
JCRB0137
|
human
|
lung (cancer)
|
adenocarcinoma, transplantable to SCID mice and frequently metastasize to lymph nodes
|
RERF-LC-MA
|
JCRB0812
|
human
|
lung (cancer)
|
small cell carcinoma, exhibits the same DNA profile as lung squamous carcinoma cell line SK-MES-1. (distribution is suspended)
|
RERF-LC-MS
|
JCRB0081
|
human
|
lung (cancer)
|
adenocarcinoma
|
RERF-LC-OK
|
JCRB0811
|
human
|
lung (cancer)
|
adenocarcinoma, (distribution is suspended)
|
RERF-LC-Sq1
|
JCRB1019
|
human
|
lung (cancer)
|
squamous carcinoma
|
RI-T
|
JCRB1088
|
rat
|
liver
|
hepatic stellate cell line immortalized with SV40 T antigen, [mycoplasma-positive] (Wistar rat)
|
RKN
|
IFO50317
|
human
|
ovary
|
leiomyosarcoma
|
RKN
|
JCRB0176
|
human
|
ovary
|
leiomyosarcoma
|
RL-33
|
JCRB0131
|
rabbit
|
lung
|
HSV,VSV sensitive, suitable for study anti-viral agents
|
RL-34
|
JCRB0247
|
rat
|
liver
|
normal, collagen-induced growth arrest, (Wistar rat)
|
RLC-10.P3
|
JCRB0718
|
rat
|
liver
|
normal liver, RLC-10 derivative, no serum required, (JAR-1 rat)
|
RLC-10.P3
|
JCRB0718.1
|
rat
|
liver
|
normal liver, RLC-10 derivative, no serum required, deposited directly by original developer (JAR-1 rat)
|
RLN-10
|
JCRB0415
|
rat
|
liver
|
normal liver, (Donryu rat)
|
RLN-8
|
JCRB0414
|
rat
|
liver
|
normal liver, (Donryu rat)
|
RLN-B2
|
JCRB0402
|
rat
|
liver
|
normal liver, (Donryu rat)
|
RLN-J-5-2
|
JCRB0407
|
rat
|
liver
|
normal liver, (Donryu rat)
|
RMG-I
|
IFO50315
|
human
|
ovary
|
clear cell carcinoma
|
RMG-I
|
JCRB0172
|
human
|
ovary
|
mesonephroid adenocarcinoma
|
RMG-II
|
IFO50316
|
human
|
ovary
|
mesonephroid cancer, (excluded from catalogue)
|
RMG-II
|
JCRB0172.1
|
human
|
ovary
|
mesonephroid adenocarcinoma
|
RMT-1 E4
|
JCRB0242
|
rat
|
mammary
|
mammary carcinoma, dimethylbenzathracene induced, (SD rat)
|
RMT-1 M2
|
JCRB0245
|
rat
|
mammary
|
mammary myoepithelial cell, dimethylbenzathracene induced, (SD rat)
|
RMUG-L
|
IFO50319
|
human
|
ovary
|
mucinous cystadenocarcinoma, (distribution is suspended, possibilty for cross-contamination with SNG-II)
|
RMUG-S
|
IFO50320
|
human
|
ovary
|
mucinous cystadenocarcinoma
|
RNB
|
IFO50491
|
rat
|
neural
|
astrocyte, GFAP-positive, (Wistar rat)
|
RP-1
|
JCRB0195
|
mouse
|
antibody-producing hybridoma
|
anti-rat neutrophil, IgG1
|
RP-3
|
JCRB0196
|
mouse
|
antibody-producing hybridoma
|
anti-rat neutrophil, IgM
|
RPMI 1788
|
IFO50037
|
human
|
hemo-lymphocytic
|
established from normal blood, IgM secreting
|
RPMI 1788
|
JCRB0035
|
human
|
hemo-lymphocytic
|
established from normal blood, IgM secreting
|
RPMI 1846
|
JCRB9087
|
hamster, Syrian
|
melanoma
|
melanotic melanoma
|
RPMI 2650
|
JCRB9058
|
human
|
nasal septum
|
quasi-diploid squamous carcinoma
|
RPMI 8226
|
IFO50013
|
human
|
hemo-lymphocytic
|
myeloma, multiple
|
RPMI 8226
|
JCRB0034
|
human
|
hemo-lymphocytic
|
myeloma, multiple
|
RS-A
|
JCRB0423
|
rat
|
spleen
|
spleen, spontaneously transformed cells, (Donryu rat)
|
RSMG-1
|
JCRB1146
|
rat
|
submandibular gland
|
submandibular gland-derived epithelial cell line, (Wistar rat)
|
RTSG
|
IFO50318
|
human
|
ovary
|
adenocarcinoma, poorly differentiated, (distribution is suspended, possiblity for cross-contamination with SNG-II)
|
S
|
Page Top
|
|
|
|
S.CET.M8.1.1
|
JCRB0011
|
mouse
|
antibody-producing hybridoma
|
anti-11-deoxycortisol, IgG
|
SAS
|
JCRB0260
|
human
|
oral
|
squamous carcinoma, tongue
|
SAT
|
JCRB1027
|
human
|
oral
|
squamous carcinoma, oral cavity
|
SBC-1
|
JCRB0816
|
human
|
lung (cancer)
|
small cell carcinoma, intermediate, JCRB0816 SBC-1 and JCRB0817 SBC-2 exhibit the same DNA profile. (distribution is suspended)
|
SBC-2
|
JCRB0817
|
human
|
lung (cancer)
|
small cell carcinoma, intermediate, JCRB0816 SBC-1 and JCRB0817 SBC-2 exhibit the same DNA profile. (distribution is suspended)
|
SBC-3
|
JCRB0818
|
human
|
lung (cancer)
|
small cell carcinoma, oat cell type
|
SBC-5
|
JCRB0819
|
human
|
lung (cancer)
|
small cell carcinoma, intermediate
|
SC78.H81.C81.A9
|
JCRB1301
|
mouse
|
antibody-producing hybridoma
|
anti-scopolamine antibody-producing. IgG1(k)
|
SCC-131
|
JCRB0230
|
rat
|
squamous cell carcinoma
|
squamous cell carcinoma
|
SCC-158
|
JCRB0231
|
rat
|
squamous cell carcinoma
|
squamous cell carcinoma
|
SCC-3
|
JCRB0115
|
human
|
hemo-lymphocytic
|
lymphoma, monocytic, non-Hodgkin's
|
SCC-4
|
JCRB9118
|
human
|
oral
|
squamous carcinoma, tongue
|
SCCH-196
|
JCRB0108
|
human
|
sarcoma
|
small round cell sarcoma
|
SCCH-26
|
JCRB0106
|
human
|
neural
|
neuroblastoma
|
SCH
|
JCRB0251
|
human
|
stomach
|
choriocarcinoma arising at stomach from male patient
|
SEKI
|
JCRB1041
|
human
|
melanoma
|
malignant melanoma, skin
|
SF126
|
IFO50286
|
human
|
neural
|
glioblastoma multiforme, GFAP-negative
|
SF-TY
|
JCRB0075
|
human
|
skin
|
normal fibroblast
|
Shay
|
JCRB0241
|
rat
|
hemo-lymphocytic
|
granurocytic sarcoma, (Wister rat)
|
SHOK
|
IFO50367
|
hamster, Syrian
|
embryo
|
fibroblast, contact-inhibited
|
Si-1
|
JCRB1369
|
monkey, Japanese macaque
|
hemo-lymphocytic
|
Japanese monkey lymphocyte line transformed with HTLV-I. (This cell line is supplied from National Institute of Biomedical Innovation.)
|
Si-2
|
JCRB1321
|
monkey, Japanese macaque
|
hemo-lymphocytic
|
STLV-I carrying Japanese monkey lymphoid cell line. (This cell line is supplied from National Institute of Biomedical Innovation.)
|
SIRC
|
IFO50020
|
rabbit
|
cornea
|
susceptible to rubella virus
|
SIRC
|
JCRB9122
|
rabbit
|
cornea
|
susceptible to rubella virus
|
SJK-237-71
|
JCRB9032
|
mouse
|
antibody-producing hybridoma
|
anti-DNA polymerase alpha, IgG1
|
SKG-I
|
IFO50308
|
human
|
uterine cervix
|
cervical epidermoid carcinoma
|
SKG-II
|
IFO50309
|
human
|
uterine cervix
|
cervical epidermoid carcinoma, large cell, non-keratinizing type
|
SKG-II
|
JCRB0171
|
human
|
uterine cervix
|
cervical epidermoid carcinoma, large cell, non-keratinizing type (excluded from catalogue)
|
SKG-IIIa
|
IFO50310
|
human
|
uterine cervix
|
cervical epidermoid carcinoma, clear cell type
|
SKG-IIIa
|
JCRB0232
|
human
|
uterine cervix
|
cervical epidermoid carcinoma, clear cell type
|
SKG-IIIb
|
IFO50311
|
human
|
uterine cervix
|
cervical epidermoid carcinoma, large cell, non-keratinizing type
|
SKG-IIIb
|
JCRB0232.1
|
human
|
uterine cervix
|
cervical epidermoid carcinoma, large cell, non-keratinizing type
|
SKM-1
|
JCRB0118
|
human
|
hemo-lymphocytic
|
myelo dysplastic syndrome
|
SK-MG-1
|
IFO50344
|
human
|
neural
|
astrocytoma, adapted to serum-free medium, derived from Marcus cells, (distribution is suspended)
|
SKN
|
IFO50314
|
human
|
uterus
|
leiomyosarcoma
|
SKN
|
JCRB0173
|
human
|
uterus
|
leiomyosarcoma
|
SKN-3
|
JCRB1039
|
human
|
oral
|
squamous carcinoma, oral cavity
|
SKNO-1
|
JCRB1170
|
human
|
hemo-lymphocytic
|
leukemia, acute myeloblastic, GM-CSF dependent
|
SLVL
|
JCRB0159
|
human
|
hemo-lymphocytic
|
lymphoma, splenic, B cell line with cytoplasmic villi
|
SNG-II
|
IFO50312
|
human
|
uterus
|
endometrial adenocarcinoma
|
SNG-II
|
JCRB0175
|
human
|
uterus
|
endometrial adenocarcinoma, (excluded from catalogue)
|
SNG-M
|
IFO50313
|
human
|
uterus
|
endometrial adenocarcinoma
|
SNG-M
|
JCRB0179
|
human
|
uterus
|
endometrial adenocarcinoma
|
Sp2/O-Ag14
|
JCRB9084
|
mouse
|
hemo-lymphocytic
|
myeloma, non-secreting, 8-azaguanine resistant
|
SR-3Y1-2
|
JCRB0742
|
rat
|
embryo
|
3Y1 derivative, transformed by Rous sarcoma virus, (Fischer rat)
|
STC 1
|
JCRB1053
|
human
|
lung (cancer)
|
small cell carcinoma
|
STK1
|
JCRB9033
|
mouse
|
antibody-producing hybridoma
|
anti-DNA polymerase alpha, IgG1
|
SUIT-2
|
JCRB1094
|
human
|
pancreas
|
pancreatic cancer, moderately differentiated tubular adenocarcinoma
|
SV
|
JCRB1207
|
mouse
|
skin
|
SV40-immortalized fibroblast line from beta-galactosidase-deficient mouse
|
SV-3Y1-C66
|
JCRB0735
|
rat
|
embryo
|
3Y1 derivative, SV40-transformed, (Fischer rat)
|
SV-T2
|
JCRB9099
|
mouse
|
embryo
|
SV40 virus-transformed BALB/3T3, (BALB/c mouse)
|
SVts-8
|
JCRB0506.1
|
human
|
lung
|
fetal lung, immortalized fibroblast transfected with ts SV40 early gene, derivative of TIG-3 cells
|
SW-13
|
JCRB9069
|
human
|
adrenal cortex
|
adenocarcinoma
|
SW837
|
JCRB9115
|
human
|
rectum
|
adenocarcinoma
|
T
|
Page Top
|
|
|
|
T.T
|
JCRB0262
|
human
|
esophagus
|
squamous carcinoma
|
T.Tn
|
JCRB0261
|
human
|
esophagus
|
squamous carcinoma, established through nude mice transplant
|
T-23 clone 8
|
JCRB0745
|
tupaia
|
lung
|
normal, applicable for the mutation assay system in vitro
|
T24
|
JCRB0711
|
human
|
bladder
|
urinary bladder carcinoma
|
T98G
|
IFO50303
|
human
|
neural
|
glioblastoma, multiforme
|
T98G
|
JCRB9041
|
human
|
neural
|
glioblastoma, multiforme
|
TaD-1
|
IFO50112
|
rat
|
thymus
|
thymoma, keratin-positive, (ACI x BUF/Mna, F1 rat)
|
TaD-1-3
|
IFO50120
|
rat
|
thymus
|
thymoma, keratin-positive, (ACI x BUF/Mna, F1 rat)
|
T-Ag-MOSE
|
JCRB0151
|
mouse
|
ovary
|
ovarian surface epithelial cell line immortalized by SV40 large T antigen, (C3H/He mouse)
|
Takigawa
|
JCRB0124
|
human
|
stomach
|
gastric carcinoma, proliferates very slowly (D.T.=2 weeks).
|
TALL-1
|
JCRB0086
|
human
|
hemo-lymphocytic
|
leukemia, acute T lymphoblastic
|
TASK1
|
JCRB0139
|
human
|
neural
|
neuroectodermal tumor
|
TCC-PAN2
|
JCRB1072
|
human
|
pancreas
|
pancreatic cancer
|
TCO-1
|
JCRB0239
|
human
|
thyroid
|
non differentiated cancer
|
TG1
|
JCRB0626
|
hamster, Chinese
|
lung
|
V79 derivative, 6-thioguanine-resistant
|
TGW
|
JCRB0618
|
human
|
neural
|
neuroblastoma, adrenal gland
|
TGW.P3
|
JCRB0618.1
|
human
|
neural
|
neuroblastoma, adrenal gland, serum-free
|
THP-1
|
JCRB0112
|
human
|
hemo-lymphocytic
|
leukemia, acute monocytic
|
THP-1
|
JCRB0112.1
|
human
|
hemo-lymphocytic
|
leukemia, acute monocytic
|
TIG-101
|
JCRB0526
|
human
|
skin
|
skin, normal diploid fibroblast (growth is slow)
|
TIG-102
|
JCRB0527
|
human
|
skin
|
skin, normal diploid fibroblast
|
TIG-103
|
JCRB0528
|
human
|
skin
|
skin, normal diploid fibroblast
|
TIG-104
|
JCRB0529
|
human
|
skin
|
skin, normal diploid fibroblast
|
TIG-105
|
JCRB0530
|
human
|
skin
|
skin, normal diploid fibroblast
|
TIG-106
|
JCRB0531
|
human
|
skin
|
skin, normal diploid fibroblast
|
TIG-107
|
JCRB0532
|
human
|
skin
|
skin, normal diploid fibroblast
|
TIG-108
|
JCRB0537
|
human
|
skin
|
skin, normal diploid fibroblast
|
TIG-109
|
JCRB0538
|
human
|
skin
|
skin, normal diploid fibroblast
|
TIG-110
|
JCRB0543
|
human
|
skin
|
skin, normal diploid fibroblast
|
TIG-111
|
JCRB0541
|
human
|
skin
|
skin, normal diploid fibroblast
|
TIG-112
|
JCRB0533
|
human
|
skin
|
skin, normal diploid fibroblast
|
TIG-113
|
JCRB0539
|
human
|
skin
|
skin, normal diploid fibroblast
|
TIG-114
|
JCRB0534
|
human
|
skin
|
skin, normal diploid fibroblast
|
TIG-118
|
JCRB0535
|
human
|
skin
|
skin, normal diploid fibroblast
|
TIG-119
|
JCRB0540
|
human
|
skin
|
skin, normal diploid fibroblast
|
TIG-120
|
JCRB0542
|
human
|
skin
|
skin, normal diploid fibroblast
|
TIG-1-20
|
JCRB0501
|
human
|
lung
|
fetal lung, normal diploid fibroblast, TIG-1, PDL=about 20
|
TIG-121
|
JCRB0536
|
human
|
skin
|
skin, normal diploid fibroblast
|
TIG-1-30
|
JCRB0502
|
human
|
lung
|
fetal lung, normal diploid fibroblast, TIG-1, PDL=about 30
|
TIG-1-40
|
JCRB0503
|
human
|
lung
|
fetal lung, normal diploid fibroblast, TIG-1, PDL=about 40
|
TIG-1-50
|
JCRB0504
|
human
|
lung
|
fetal lung, normal diploid fibroblast, TIG-1, PDL=about 50
|
TIG-1-60
|
JCRB0505
|
human
|
lung
|
fetal lung, normal diploid fibroblast, TIG-1, PDL=about 60
|
TIG-2M-30
|
JCRB0525
|
human
|
muscular system
|
muscle, normal diploid fibroblast (not myoblast), PDL=about 30
|
TIG-3-20
|
JCRB0506
|
human
|
lung
|
fetal lung, normal diploid fibroblast, TIG-3, PDL=about 20
|
TIG-3-30
|
JCRB0507
|
human
|
lung
|
fetal lung, normal diploid fibroblast, TIG-3, PDL=about 30
|
TIG-3-40
|
JCRB0508
|
human
|
lung
|
fetal lung, normal diploid fibroblast, TIG-3, PDL=about 40
|
TIG-3-50
|
JCRB0509
|
human
|
lung
|
fetal lung, normal diploid fibroblast, TIG-3, PDL=about 50
|
TIG-3-60
|
JCRB0510
|
human
|
lung
|
fetal lung, normal diploid fibroblast, TIG-3, PDL=about 60
|
TIG-3S
|
JCRB0544
|
human
|
skin
|
skin, normal diploid fibroblast
|
TIG-7-20
|
JCRB0511
|
human
|
lung
|
fetal lung, normal diploid fibroblast, TIG-7, PDL=about 20
|
TIG-7-30
|
JCRB0512
|
human
|
lung
|
fetal lung, normal diploid fibroblast, TIG-7, PDL=about 30
|
TIG-7-40
|
JCRB0513
|
human
|
lung
|
fetal lung, normal diploid fibroblast, TIG-7, PDL=about 40
|
TIG-7-50
|
JCRB0514
|
human
|
lung
|
fetal lung, normal diploid fibroblast, TIG-7, PDL=about 50
|
TIG-7-60
|
JCRB0515
|
human
|
lung
|
fetal lung, normal diploid fibroblast, TIG-7, PDL=about 60
|
TK
|
JCRB0157
|
human
|
hemo-lymphocytic
|
lymphoma, malignant, B-cell
|
TK
|
JCRB1206
|
human
|
hemo-lymphocytic
|
lymphoma, malignant (arising at brain). This cell line is different from JCRB0157 TK.
|
TK-1
|
JCRB0128
|
human
|
neural
|
glioblastoma multiforme, contamination by U-251 MG was suspected
|
TKC2
|
IFO50373
|
mouse
|
kidney
|
tubule cell, tsSV40 large T-immortalized, (C57BL/6 transgenic mouse)
|
TKD2
|
IFO50374
|
mouse
|
vascular system
|
endothelial cell, tsSV40 large T-immortalized, (C57BL/6 transgenic mouse)
|
TLR2
|
IFO50379
|
mouse
|
liver
|
hepatocyte, tsSV40 large T-immortalized, (C57BL/6 transgenic mouse)
|
TLR3
|
IFO50380
|
mouse
|
liver
|
hepatocyte, tsSV40 large T-immortalized, (C57BL/6 transgenic mouse)
|
TMD5
|
IFO50516
|
human
|
hemo-lymphocytic
|
leukemia, acute B lymphoblastic, double Philadelphia chromosomes
|
TMH-1
|
JCRB1078
|
human
|
thyroid
|
thyroid anaplastic carcinoma,(contamination by IHH-4 is suspected.)
|
ts85
|
JCRB0705
|
mouse
|
mammary
|
FM3A derivative, defective in ubiquitin activating enzyme, (C3H mouse)
|
tsFT101
|
JCRB0706
|
mouse
|
mammary
|
FM3A derivative, cytokinesis is blocked at 39 C, (C3H mouse)
|
tsJT16
|
JCRB0153.2
|
rat
|
embryo
|
3Y1-derivative, ts mutation for cell cycle progression from G0 and G1 to S phase, (Fischer rat)
|
tsJT60
|
JCRB0153.3
|
rat
|
embryo
|
3Y1-derivative, ts mutant cell line with cell cycle arrest at G0 phase, (Fischer rat)
|
tsJT663
|
JCRB0153.1
|
rat
|
embryo
|
3Y1-derivative, ts mutation for cell cycle progression from G1 to S phase, (Fischer rat)
|
TuD-1
|
IFO50103
|
rat
|
thymus
|
thymic stroma, keratin-positive, (ACI rat)
|
TuD-1-3
|
IFO50152
|
rat
|
thymus
|
thymic stroma, keratin-positive, (ACI rat)
|
Ty-82
|
JCRB1330
|
human
|
thymus
|
undifferentiated thymic carcinoma
|
TYK-nu
|
JCRB0234.0
|
human
|
ovary
|
undifferentiated carcinoma
|
TYK-nu.CP-r
|
JCRB0234.1
|
human
|
ovary
|
undifferentiated carcinoma, cisplatin-resistant
|
U
|
Page Top
|
|
|
|
U-251 MG
|
IFO50288
|
human
|
neural
|
astrocytoma, GFAP-positive
|
U-251 MG (KO)
|
IFO50285
|
human
|
neural
|
astrocytoma, GFAP-positive
|
U937
|
JCRB9021
|
human
|
hemo-lymphocytic
|
lymphoma, diffuse histiocytic, monocyte-like characteristics
|
U-937
|
IFO50038
|
human
|
hemo-lymphocytic
|
lymphoma, diffuse histiocytic, monocyte-like characteristics
|
U937 cl1-14
|
JCRB0116.1
|
human
|
hemo-lymphocytic
|
lymphoma, histiocytic, highly susceptible clone of U937 for HIV
|
U937 cl1-22
|
JCRB0116.2
|
human
|
hemo-lymphocytic
|
lymphoma, histiocytic, low susceptible clone of U937 for HIV
|
UBE6T-15
|
JCRB1159
|
human
|
mesenchymal stem cell
|
mesenchymal stem cells from bone marrow, hTERT, HPV E6, bmi-1-introduced, immortalized
|
UBE6T-6
|
JCRB1140
|
human
|
mesenchymal stem cell
|
mesenchymal stem cells from bone marrow, hTERT, HPV E6, bmi-1-introduced, immortalized
|
UBE6T-7
|
JCRB1143
|
human
|
mesenchymal stem cell
|
mesenchymal stem cells from bone marrow, hTERT, HPV E6, bmi-1-introduced, immortalized
|
UC701
|
JCRB1218
|
human
|
umbilical cord
|
normal umbilical cord-derived cells with fibroblastic morphology, limited life span
|
UC702
|
JCRB1220
|
human
|
umbilical cord
|
normal umbilical cord-derived cells with fibroblastic morphology, limited life span
|
UC704
|
JCRB1224
|
human
|
umbilical cord
|
normal umbilical cord-derived cells with fibroblastic morphology, limited life span
|
UCB302MSCs
|
JCRB1106
|
human
|
mesenchymal stem cell
|
mesenchymal stem cells from umbilical cord blood, limited life span, (growth is very slow.)
|
UCB408E6E7-31
|
JCRB1108
|
human
|
mesenchymal stem cell
|
mesenchymal stem cells from umbilical cord blood, HPV E6, E7-introduced, limited life span
|
UCB408E6E7TERT-33
|
JCRB1110
|
human
|
mesenchymal stem cell
|
mesenchymal stem cells from umbilical cord blood, hTERT and HPV E6, E7-introduced, immortalized
|
UCB408E7-32
|
JCRB1109
|
human
|
mesenchymal stem cell
|
mesenchymal stem cells from umbilical cord blood, HPV E7-introduced, limited life span
|
UCBTERT-21
|
JCRB1107
|
human
|
mesenchymal stem cell
|
mesenchymal stem cells from umbilical cord blood, hTERT-immortalized
|
UE6E7-16
|
JCRB1160
|
human
|
mesenchymal stem cell
|
mesenchymal stem cells from bone marrow, HPV E6, E7-introduced, limited life span
|
UE6E7T-11
|
JCRB1149
|
human
|
mesenchymal stem cell
|
mesenchymal stem cells from bone marrow, hTERT and HPV E6, E7-introduced, immortalized
|
UE6E7T-12
|
JCRB1151
|
human
|
mesenchymal stem cell
|
mesenchymal stem cells from bone marrow, hTERT and HPV E6, E7-introduced, immortalized
|
UE6E7T-2
|
JCRB1133
|
human
|
mesenchymal stem cell
|
mesenchymal stem cells from bone marrow, hTERT and HPV E6, E7-introduced, immortalized
|
UE6E7T-3
|
JCRB1136
|
human
|
mesenchymal stem cell
|
mesenchymal stem cells from bone marrow, hTERT and HPV E6, E7-introduced, immortalized
|
UE7T-13
|
JCRB1154
|
human
|
mesenchymal stem cell
|
mesenchymal stem cells from bone marrow, hTERT and HPV E7-introduced, immortalized
|
UE7T-9
|
JCRB1147
|
human
|
mesenchymal stem cell
|
mesenchymal stem cells from bone marrow, hTERT and HPV E7-introduced, immortalized
|
V
|
Page Top
|
|
|
|
V79
|
JCRB0603
|
hamster, Chinese
|
lung
|
fibroblast
|
V79 379A
|
IFO50082
|
hamster, Chinese
|
lung
|
lung, fibroblast, widely used in somatic genetics
|
V79 HPRT~
|
JCRB0707
|
hamster, Chinese
|
lung
|
V79 derivative, HPRT-deficient
|
V79-6TG
|
JCRB0219
|
hamster, Chinese
|
lung
|
6-thioguanine-resistant V79 cell line
|
Vero
|
IFO50471
|
monkey, African green
|
kidney
|
useful to assay mycoplasmas
|
VERO
|
JCRB0111
|
monkey, African green
|
kidney
|
normal, contact inhibited
|
VERO
|
JCRB9013
|
monkey, African green
|
kidney
|
normal, contact inhibited
|
VERO 76
|
IFO50410
|
monkey, African green
|
kidney
|
normal, contact inhibited, lower saturation density than the original Vero
|
VERO 76
|
JCRB9007
|
monkey, African green
|
kidney
|
normal, contact inhibited, lower saturation density than the original Vero
|
VMRC-LCD
|
JCRB0814
|
human
|
lung (cancer)
|
adenocarcinoma
|
VMRC-LCP
|
JCRB0103
|
human
|
lung (cancer)
|
squamous cell carcinoma
|
VMRC-MELG
|
JCRB0074
|
human
|
melanoma
|
malignant melanoma, colon
|
VMRC-RCW
|
JCRB0813
|
human
|
kidney
|
renal cell carcinoma
|
VMRC-RCZ
|
JCRB0827
|
human
|
kidney
|
renal carcinoma
|
W
|
Page Top
|
|
|
|
WB-F344
|
JCRB0193
|
rat
|
liver
|
liver epithelial cell line, reported as oval cell-like, (Fischer F344 rat)
|
WEHI-3
|
JCRB9093
|
mouse
|
hemo-lymphocytic
|
leukemia, myelomonocytic, macrophage-like, (BALB/c mouse)
|
WEHI-3b
|
IFO50296
|
mouse
|
hemo-lymphocytic
|
myelomonocyte, (BALB/c mouse)
|
WI-26 VA4
|
JCRB9042
|
human
|
lung
|
fetal lung, SV40 virus transformed, derivative of WI-26
|
WI-38
|
IFO50075
|
human
|
lung
|
fetal lung, normal diploid fibroblast
|
WI-38
|
JCRB9017
|
human
|
lung
|
fetal lung, normal diploid fibroblast
|
WI-38 VA13 sub 2 RA
|
JCRB9057
|
human
|
lung
|
fetal lung, SV40 virus transformed, derivative of WI-38
|
WI-38-30
|
JCRB0517
|
human
|
lung
|
fetal lung, normal diploid fibroblast, PDL=about 30, (not available)
|
WI-38-40
|
JCRB0518
|
human
|
lung
|
fetal lung, normal diploid fibroblast, PDL=about 40
|
WiDr
|
IFO50043
|
human
|
colon
|
adenocarcinoma
|
WiDr
|
JCRB0224
|
human
|
colon
|
adenocarcinoma
|
WIL2-NS
|
JCRB9063
|
human
|
hemo-lymphocytic
|
B lymphocyte line, from patient with hereditary spherocytic anemia, non-immunoglobulin secreting variant
|
WISH
|
IFO50004
|
human
|
HeLa-contaminant
|
originally established from amnion, HeLa-contaminated
|
X
|
Page Top
|
|
|
|
XC
|
IFO50017
|
rat
|
sarcoma
|
RSV-induced sarcoma, useful for assay of murine leukemia virus, (Wistar rat)
|
XP2OS(SV)
|
JCRB0301
|
human
|
skin
|
xeroderma pigmentosum (A), SV40 transformed
|
XP2SA
|
JCRB0305
|
human
|
skin
|
xeroderma pigmentosum (variant type), fibroblast
|
XP2YO(SV)
|
JCRB0302
|
human
|
skin
|
xeroderma pigmentosum (F), SV40 transformed
|
XP35OS
|
JCRB0304
|
human
|
skin
|
xeroderma pigmentosum (A), fibroblast
|
XP39OS
|
JCRB0326
|
human
|
skin
|
xeroderma pigmentosum (A), fibroblast
|
XP39OSTERT
|
JCRB1057
|
human
|
skin
|
xeroderma pigmentosum (A), fibroblast, immortalized by hTERT
|
XP3OS
|
JCRB0303
|
human
|
skin
|
xeroderma pigmentosum (A), fibroblast
|
XP3OS(SVT)
|
JCRB1055
|
human
|
skin
|
xeroderma pigmentosum (A), fibroblast, immortalized by SV40 large T
|
XP40OS
|
JCRB0327
|
human
|
skin
|
xeroderma pigmentosum (C), fibroblast
|
XP40OSTERT
|
JCRB1058
|
human
|
skin
|
xeroderma pigmentosum (C), fibroblast, immortalized by hTERT
|
XPEMB-1
|
JCRB0325
|
human
|
skin
|
xeroderma pigmentosum (A), embryo fibroblast
|
XPL15OS
|
JCRB0307
|
human
|
hemo-lymphocytic
|
xeroderma pigmentosum (A), lymphoblastoid
|
XPL3KA
|
JCRB0306
|
human
|
hemo-lymphocytic
|
xeroderma pigmentosum (C), lymphoblastoid
|
Y
|
Page Top
|
|
|
|
Y-1
|
JCRB9056
|
mouse
|
adrenal cortex
|
adrenocortical tumor, steroid-secreting, (LAF1 mouse)
|
Y3-Ag 1.2.3
|
JCRB9091
|
rat
|
hemo-lymphocytic
|
myeloma, kappa secreting, 8-azaguanine resistant, (Lou rat)
|
YG10003
|
JCRB0119
|
hamster, Chinese
|
lung
|
salmonella O-acetyltransferase gene introduced CHL cells
|
YG10007
|
JCRB0120
|
hamster, Chinese
|
lung
|
human monomorphic N-acetyltransferase gene introduced CHL cells
|
YG10008
|
JCRB0121
|
hamster, Chinese
|
lung
|
human polymorphic N-acetyltransferase gene transfected CHL cells
|
YH-13
|
IFO50493
|
human
|
neural
|
glioblastoma, GFAP and S-100-positive, ACNU(a cancer chemotherapy drug)-resistant
|
YKG-1
|
JCRB0746
|
human
|
neural
|
glioblastoma
|
YMB-1
|
JCRB0823
|
human
|
mammary
|
breast cancer, exhibit the same DNA profile as other breast carcinoma cell line ZR-75-1.
|
YMB-1-E
|
JCRB0825
|
human
|
mammary
|
breast cancer, exhibit the same DNA profile as other breast carcinoma cell line ZR-75-1.
|
YSK
|
JCRB0619
|
rat
|
*****
|
*****
|
Yub 10F
|
JCRB1116
|
human
|
mesenchymal stem cell
|
from polydactylous finger
|
Yub621b
|
JCRB1112
|
human
|
mesenchymal stem cell
|
from polydactylous finger
|
Yub621BMC
|
JCRB1113
|
human
|
mesenchymal stem cell
|
from polydactylous finger, bone marrow
|
Yub621c
|
JCRB1111
|
human
|
mesenchymal stem cell
|
from polydactylous finger, cartilage
|
Yub622
|
JCRB1114
|
human
|
mesenchymal stem cell
|
from polydactylous finger
|
Yub623
|
JCRB1115
|
human
|
mesenchymal stem cell
|
from polydactylous finger
|
Yub625
|
JCRB1155
|
human
|
mesenchymal stem cell
|
from polydactylous finger
|
Yub631
|
JCRB1156
|
human
|
mesenchymal stem cell
|
from polydactylous finger
|
Yub632
|
JCRB1157
|
human
|
mesenchymal stem cell
|
from polydactylous finger
|
Yub633
|
JCRB1158
|
human
|
mesenchymal stem cell
|
from polydactylous finger
|
Yub634
|
JCRB1161
|
human
|
mesenchymal stem cell
|
from polydactylous finger
|
Yub635
|
JCRB1162
|
human
|
mesenchymal stem cell
|
from polydactylous finger
|
Yub636
|
JCRB1169
|
human
|
mesenchymal stem cell
|
from polydactylous finger, bone marrow
|
Yub637b
|
JCRB1163
|
human
|
mesenchymal stem cell
|
from polydactylous finger, bone
|
Yub637s
|
JCRB1173
|
human
|
mesenchymal stem cell
|
from polydactylous finger, skin
|
Yub642
|
JCRB1172
|
human
|
mesenchymal stem cell
|
from polydactylous finger
|
Yub642b
|
JCRB1174
|
human
|
mesenchymal stem cell
|
from polydactylous finger, bone
|
Yub642p
|
JCRB1171
|
human
|
mesenchymal stem cell
|
from polydactylous finger, periosteum
|
Z-
|
Page Top
|
|
|
|
ZEN
|
JCRB1311
|
mouse
|
antibody-producing hybridoma
|
anti-zearalenone, IgG1(lambda)
|